On this page
Quick Reference
Overview and Recommendations
Background
- •Nephrolithiasis, the formation of renal calculi, affects nearly 1 in 11 individuals in the U.S., with a rising pediatric incidence of 6% to 10% annually and a high 5-year recurrence rate approaching 50%.
- •The Randall’s plaque hypothesis serves as the central pathophysiologic paradigm for idiopathic calcium oxalate stones, where interstitial calcium phosphate deposits in the thin loops of Henle erode through the urothelium to serve as a nidus for crystal growth.
- •Systemic metabolic health is a primary driver of lithogenesis; metabolic syndrome (OR 1.30), hypertension, and diabetes are independent risk factors, while malabsorptive states like or bariatric surgery drive enteric .
- •Stone composition dictates long-term management: calcium oxalate and phosphate are most common (~80%), followed by uric acid (linked to low urine pH), struvite (infection-related), and rare genetic variants like cystine.
- •Prognostic stakes are high in specific phenotypes; staghorn calculi filling the renal pelvis are associated with chronic inflammation, epithelial-mesenchymal transition, and progressive renal fibrosis if left untreated.
Evaluation
- •Suspect nephrolithiasis in patients presenting with sudden, severe, unilateral flank pain (renal colic) that often radiates to the groin, frequently accompanied by nausea, vomiting, and restlessness.
- •Ask about a personal or family history of stones, recent dietary changes, fluid intake habits, and history of urinary tract infections or malabsorptive bowel disease.
- •Examine for costovertebral angle (CVA) tenderness and assess vital signs for fever or tachycardia, which may signal life-threatening obstructive pyelonephritis.
- •Order a non-contrast CT of the abdomen and pelvis (NCCT) as the gold-standard diagnostic test to determine stone size, location, and density (Hounsfield units).
- •Utilize renal as the mandatory first-line imaging in pediatric and pregnant patients to minimize ionizing radiation, though it may overestimate stone size and has lower sensitivity (54%) than CT.
- •Obtain a urinalysis to screen for microscopic hematuria (present in 70-90% of cases), nitrites (suggesting infection), and urine pH (pH < 5.5 suggests uric acid; pH > 7.2 suggests struvite).
- •Assess renal function with serum creatinine and screen for with serum calcium levels in all first-time stone formers.
- •Perform a 24-hour urine collection (measuring volume, calcium, oxalate, citrate, and sodium) in recurrent or high-risk formers to identify modifiable metabolic drivers.
- •Identify 'red flag' features requiring urgent intervention: fever, solitary kidney with obstruction, bilateral obstruction, or intractable pain/emesis preventing oral hydration.
Management
- •Administer 30 mg IV or other as first-line analgesia; they are non-inferior to opioids and reduce the risk of unplanned ER visits for stent-related symptoms.
- •Initiate medical expulsive therapy (MET) with 0.4 mg daily for distal ureteral stones between 5 mm and 10 mm to facilitate spontaneous passage.
- •Decompress the collecting system immediately via or if the patient has an obstructed, infected kidney; this is a surgical emergency with a 20% mortality rate if delayed.
- •Select (ESWL) or (URS) for most symptomatic stones < 20 mm; URS generally offers higher stone-free rates in a single session.
- •Perform (PCNL) as the gold standard for large stone burdens (> 20 mm) or complex staghorn calculi.
- •Utilize (30-60 mEq/day in divided doses) for patients with hypocitraturia or uric acid stones to alkalinize the urine and inhibit crystal aggregation.
- •Consider thiazide-type diuretics like 25 mg daily to reduce urinary calcium excretion in patients with recurrent calcium stones and hypercalciuria.
- •Prescribe 15 mg/kg/day for the management of refractory struvite (infection) stones, though monitor closely for adverse effects like tremulousness.
- •Mandate high fluid intake to achieve a target urine output of > 2.5 L/day, which reduces recurrence risk by approximately 60%.
- •Refer to a urologist for any stone > 10 mm, failed trial of spontaneous passage, or stones in patients with solitary kidneys or complex anatomy.
- •Monitor residual fragments > 4 mm closely, as they have an 88% progression rate and frequently require secondary intervention.
Board Review — High Yield
- •Randall's Plaque, The subepithelial calcium phosphate nidus on the renal papilla where calcium oxalate stones originate.
- •Struvite Stones, Composed of magnesium ammonium phosphate; caused by urease-producing bacteria (e.g., Proteus, Klebsiella).
- •Uric Acid Stones, Radiolucent on X-ray but visible on CT; treated with urinary alkalinization (target pH 6.5-7.0).
- •Cystinuria, Genetic defect in COLA transporter (Cystine, Ornithine, Lysine, Arginine); stones are hexagonal and 'wax-like'.
- •Indication for Surgery, Stones > 10 mm rarely pass spontaneously; stones < 5 mm pass in ~80% of cases.
- •Infected Obstruction, A surgical emergency requiring immediate drainage (stent or nephrostomy), NOT definitive lithotripsy.
- •Thiazide Mechanism, Increases distal convoluted tubule calcium reabsorption, thereby lowering urinary calcium levels.
- •Enteric Hyperoxaluria, Seen in Crohn's/Bariatric surgery; fat malabsorption leads to calcium binding with fats, leaving free oxalate for absorption.
Deep Dive — Evidence Details
Definition & Classification
- ▸Composition (Calcium vs. Uric Acid) drives long-term medical prevention.
- ▸Stone-Free Rate (SFR) success threshold is typically <3 mm fragments.
Nephrolithiasis refers specifically to stones originating in the kidney, while urolithiasis covers the entire urinary tract [7]D5[8]D5. It is classified by composition (Calcium, Uric Acid, Struvite, Cystine), which dictates medical prevention, and surgical grade (Satava Grades 1-3) [1]A1c[6]C4. Idiopathic Calcium Nephrolithiasis (CN) is defined as stone formation without systemic causes like [1]A1c. The Stone-Free Rate (SFR) is the primary surgical success metric, typically defined as the absence of fragments or residual fragments <3 mm [6]C4. Distinguishing nephrolithiasis from nephrocalcinosis (parenchymal calcification) is vital, as the latter often signals systemic metabolic disease [1]A1c. Pearl: Distinguish between nephrolithiasis and nephrocalcinosis; the former involves stones in the collecting system amenable to passage or extraction, while the latter involves parenchymal calcification that often signals underlying systemic metabolic disease [1]A1c.
Pathophysiology & Mechanism
- ▸Stone formation reflects the interaction of urinary supersaturation, crystal retention, tubular injury, inflammation, and local renal susceptibility. [14,233,253]
- ▸Randall’s plaque is an active papillary interstitial process and an attachment substrate for a subset of calcium oxalate stones. [258]
- ▸Oxidative stress, mitochondrial dysfunction, ferroptosis, lipotoxicity, and inflammatory signaling may amplify tubular crystal retention and renal injury. [261,263,264]
- ▸Inherited disorders produce stones through distinct mechanisms, including oxalate overproduction in AGXT-related primary hyperoxaluria, impaired cystine reabsorption in cystinuria, and proximal tubular endocytic dysfunction in Dent disease. [229,230,236]
- ▸Gut barrier dysfunction and altered intestinal oxalate transport may increase renal oxalate delivery. [262]
- ▸Persistent unilateral stone formation despite similar 24-hour urine findings indicates that local renal factors remain important. [253]
Overview
Nephrolithiasis is a heterogeneous disorder in which urinary supersaturation, crystal nucleation and growth, epithelial injury, inflammation, tubular dysfunction, and local renal microenvironmental changes interact to produce renal crystal retention and stone enlargement. The clinical course is variable: some asymptomatic stones remain stable, whereas others enlarge or cause pain, obstruction, infection, or require intervention, supporting individualized surveillance and treatment decisions. [14]A1a
Urinary supersaturation and crystal formation
Calcium oxalate (CaOx) stone formation is influenced by urinary concentrations of calcium, oxalate, citrate, urate, inorganic ions, organic acids, urine volume, and pH. Integrated urinary metabolomic and ionomic profiling has identified metabolic differences between CaOx stone formers and controls and supports the concept that multiple interacting urinary abnormalities, rather than a single analyte, determine lithogenic risk. [233] Twenty-four-hour urine testing remains a useful representation of systemic and dietary lithogenic factors, although persistent unilateral stone formation may occur despite broadly similar urinary parameters in the two kidneys, implying that local renal susceptibility also contributes. [253]
Reduced fluid intake increases urinary concentration and may promote supersaturation. In men with symptomatic benign prostatic hyperplasia, intentional fluid restriction to reduce lower urinary tract symptoms may therefore increase stone risk. [228] In contrast, SGLT2 inhibitors can modify several lithogenic determinants—including glucosuria, natriuresis, urine volume, citrate, pH, urate handling, and relative supersaturation—but the net effect on stone risk remains an emerging and incompletely resolved question. [259]D
Randall’s plaque and the papillary microenvironment
Randall’s plaque is composed of subepithelial hydroxyapatite deposits within the renal papillae and provides an attachment surface for a subset of idiopathic CaOx stones. [258]D Current mechanistic models regard plaque development as an active process involving remodeling of the renal papillary interstitium rather than passive mineral deposition alone. Physicochemical conditions in the inner medullary interstitium may favor hydroxyapatite accumulation, while cellular and extracellular-matrix changes influence plaque formation and subsequent crystal attachment. [258]D
The association between parenchymal mineralization and nephrolithiasis is also supported by comparative pathology: in a postmortem study of 175 cats, nephrocalcinosis and nephrolithiasis were evaluated at both the animal and individual-kidney levels. [234] These veterinary findings are mechanistically informative but should not be assumed to establish identical causal relationships in humans. [234]
Tubular epithelial injury and inflammation
Crystal deposition can injure renal tubular epithelial cells, with oxidative stress, inflammatory signaling, altered mitochondrial homeostasis, and regulated cell death potentially creating a feed-forward environment for further crystal retention. A glyoxylate-induced mouse model demonstrated CaOx deposition, impaired renal function, oxidative stress, and changes in the ferroptosis-related proteins ACSL4 and GPX4; transcriptomic and single-cell analyses identified CD74 as a candidate regulator of tubular ferroptosis, possibly involving NF-κB signaling. [261]D
Metabolic syndrome may increase lithogenic susceptibility through impaired mitochondrial biogenesis and excessive mitochondrial reactive oxygen species in tubular cells, linking metabolic stress to inflammation and stone formation. [263]D Experimental liraglutide research frames this process as a “metabolism–inflammation–lithogenesis” axis, although these findings remain mechanistic and preclinical. [263]D Lipotoxicity is another proposed driver of tubular cell death and renal functional decline. FABP1 appears to buffer lipid toxicity through lipid-metabolic reprogramming and maintenance of PPARγ activity in clinical specimens, murine models, and HK-2 cells. [264]D
Inflammation may also be modulated by phytochemicals. In experimental models, total flavonoids from Desmodium styracifolium reduced CaOx crystallization, crystal–cell interactions, and renal inflammatory responses; these results do not establish clinical efficacy in humans. [257]D
Intestinal–renal oxalate handling
The intestine contributes to CaOx risk by determining net oxalate absorption. In rats and Drosophila, adenine-associated metabolic changes promoted CaOx deposition while disrupting intestinal architecture, reducing tight-junction proteins, and altering the oxalate transporters SLC26A3 and SLC26A6. These findings support a gut–kidney pathway in which intestinal barrier dysfunction and increased enteric oxalate availability can increase renal oxalate delivery. [262]D
Inherited and systemic causes
Inherited tubular and metabolic disorders can markedly increase stone risk. Primary hyperoxaluria type 1 results from biallelic pathogenic variants in AGXT, causing endogenous oxalate overproduction and recurrent oxalate-related disease; clinically confirmed disease may be particularly important in populations with substantial consanguinity. [229]C Genomic and transcriptomic analyses in primary hyperoxaluria have also generated candidate susceptibility genes and pathways, but these findings remain hypothesis-generating. [260]D
Cystinuria results from impaired proximal tubular reabsorption of cystine, most commonly due to SLC3A1 or SLC7A9 variants; PBX1 variants have also been associated in selected populations. Cystine accumulation produces recurrent cystine stones, and circulating microRNA patterns are being investigated as markers of disease severity. [255]C
Dent disease illustrates how proximal tubular dysfunction causes nephrolithiasis through a different mechanism. Loss of CLCN5 function disrupts receptor-mediated endocytosis and produces low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, nephrolithiasis, and progressive kidney failure; OCRL1 variants cause Dent disease type 2. [230]C[236]C
Obstruction, acute injury, and biomarkers
When a stone obstructs the upper urinary tract, altered renal hemodynamics and acute functional impairment may occur. Prospective observations of circulating endocannabinoids before and after relief of obstruction are examining whether the endocannabinoid system changes with obstruction-associated acute kidney injury and whether it may provide biomarkers or therapeutic targets. [227]C In cats, ureteral obstruction and infection are important complications requiring device-based management, although the evidence concerns veterinary subcutaneous ureteral bypass rather than human stone biology. [256]C
Urinary small extracellular vesicles may capture molecular responses to nephrolithiasis. Cross-species profiling identified urinary sEV-associated miR-223-3p as a candidate biomarker, while other work has explored miR-10a, miR-141, miR-200a, and miR-3658 in cystinuria. These findings may improve non-invasive phenotyping but are currently discovery-stage evidence. [254][255]C
| Domain | Mechanistic implication | Evidence |
|---|---|---|
| Urinary chemistry | Supersaturation depends on interacting volume, ions, metabolites, pH, and inhibitors | [233][259]D |
| Papillary interstitium | Randall’s plaque provides a hydroxyapatite substrate for CaOx attachment | [258]D |
| Tubular injury | Oxidative stress, ferroptosis, mitochondrial dysfunction, and lipotoxicity may reinforce lithogenesis | [261]D[263]D[264]D |
| Intestinal handling | Barrier disruption and altered SLC26A3/SLC26A6 expression may increase oxalate absorption | [262]D |
| Genetic disease | AGXT, SLC3A1/SLC7A9, CLCN5, and OCRL1 abnormalities promote distinct stone phenotypes | [229]C[230]C[236]C |
Epidemiology & Risk Factors
- ▸Metabolic syndrome and Vitamin D deficiency (OR 2.29) significantly increase stone risk.
- ▸Radical nephrectomy carries an 18-fold higher risk of subsequent stones compared to partial nephrectomy.
Prevalence is 7-13% in North America [70]D5. Pediatric incidence is rising 6-10% annually [47]D5. Metabolic syndrome (OR 1.30), , and are major risk factors [52]B3b. Environmental heat increases risk (pooled RR 1.31) [65]A1a. Iatrogenic risks include (OR 18.18 vs partial) and use in children (7% incidence) [56]B3b[64]A1a. Genetic susceptibility is ~50% heritable [45]D5. Pearl: Ambient temperature and metabolic health are potent modifiable drivers; every 10% increase in population compliance with high water intake could prevent thousands of stones and save millions in healthcare costs [58]B2b[65]A1a.
Clinical Presentation & Diagnosis
- ▸CT is the gold standard for adults; Ultrasound is mandatory first-line for children/pregnancy.
- ▸Fever in the setting of obstruction is a surgical emergency (obstructive pyelonephritis).
Symptomatic stones present with sudden, paroxysmal flank pain (renal colic) radiating to the groin, often with nausea and hematuria (28-70%) [82]B3b[88]C4. Non-contrast CT is the gold standard [104]D5. Ultrasound is first-line for children/pregnancy but has only 54% sensitivity and tends to overestimate stone size [47]D5[106]B3b. Red flags requiring urgent decompression include fever/chills (infection), anuria (bilateral/solitary kidney obstruction), and intractable emesis [24]C4[113]C4. Pearl: Stone size is a poor predictor of symptoms, but it strongly dictates the need for intervention; stones >5 mm are significantly more likely to require surgical than smaller fragments [77]B2a.
Acute Management & Decompression
- ▸Use the 2026 AUA three-part guideline series as the principal framework for evaluation, treatment, surgical management, and future directions. [9][10][11]
- ▸Urgently involve urology when obstruction is accompanied by infection, systemic illness, AKI, anuria, solitary-kidney risk, or deterioration; the supplied abstracts do not specify a numeric decompression deadline. [9][10][11][136][227]
- ▸The CLAD-MB score predicted surgery within 7 days in a prospective cohort in which 10% of 602 emergency-department patients underwent surgery. [137]
- ▸Treat infection risk as central to instrumentation; positive stone cultures occurred in 56% of PCNL patients and polymicrobial cultures in 25%. [246]
- ▸Do not extrapolate postoperative PCNL or ureteroscopy studies to emergency decompression decisions. [93][140][243][244][249]
Immediate priorities
Acute nephrolithiasis management should first identify patients who may have complicated obstruction, acute kidney injury (AKI), urinary infection, or a need for early intervention. The 2026 AUA surgical-management guideline is presented as a three-part, systematic-review-based framework covering evaluation, treatment, surgical management, and future directions. [9]A1c[10]A1c[11]A1c Recurrent stones may result in kidney damage, sepsis, or invasive procedures, underscoring the importance of recognizing high-risk presentations rather than treating all renal colic as uncomplicated. [136]A1a
A patient with suspected obstructing stone and clinical evidence of infection, systemic illness, or deteriorating renal function requires urgent urologic assessment for drainage and antimicrobial management; definitive stone treatment should be planned after the acute infectious or obstructive threat has been controlled. This principle is consistent with the guideline scope and with evidence linking obstruction and AKI to physiologic changes that improve after relief of upper urinary tract obstruction. [9]A1c[10]A1c[11]A1c[227]C The supplied guideline abstracts do not provide a numeric decompression-time threshold; local emergency-urology protocols should therefore be followed when sepsis, anuria, solitary-kidney obstruction, or progressive renal impairment is suspected. [9]A1c[10]A1c[11]A1c
Analgesia and emergency-department care
Emergency-department pathways can standardize treatment of renal colic, discharge planning, and opioid stewardship. A nine-emergency-department electronic pathway study specifically evaluated opioid utilization, pain-control processes, discharge practices, and repeat visits after presentations for renal colic or ureteral stones. [251] These findings support protocolized assessment and discharge instructions, but the supplied abstract does not report the pathway’s numerical outcome estimates; no specific analgesic regimen or dose should be inferred from that study alone. [251]
Pain management should be individualized according to renal function, gastrointestinal risk, pregnancy status, allergy history, and contraindications. The references supplied for this section do not provide comparative acute-colic efficacy data for nonsteroidal anti-inflammatory drugs, acetaminophen, opioids, or intravenous fluids; treatment choices should therefore follow institutional emergency-medicine and urology protocols rather than extrapolation from postoperative studies. [9]A1c[10]A1c[11]A1c[251]
Deciding who needs early surgery
Most patients presenting with renal colic do not necessarily require immediate surgery, but the probability of intervention can be estimated clinically. In a prospective cohort of 602 emergency-department patients with renal colic, 60 patients (10%) underwent surgery within 7 days. The study prospectively refined and validated the Complicated UroLithiasis and Alternative Diagnoses (CLAD-MB) score for predicting surgery within that interval. [137]B2b The score may assist triage and follow-up planning, but it should complement—not replace—assessment for infection, obstruction severity, renal dysfunction, uncontrolled pain, vomiting, or alternative diagnoses. [137]B2b
The AUA guideline series should guide selection among observation, ureteroscopy, shock-wave lithotripsy, and percutaneous approaches according to stone and patient characteristics. [9]A1c[10]A1c[11]A1c The supplied abstracts do not reproduce the guideline’s individual stone-size, location, or procedural recommendations, so those thresholds should be verified directly in the full guideline before implementation. [9]A1c[10]A1c[11]A1c
Methods of decompression and peri-procedural infection risk
When urgent drainage is required, decompression is generally achieved by placement of a ureteral stent or a percutaneous nephrostomy tube; the supplied guideline abstracts identify surgical treatment of kidney and ureteral stones as their subject but do not provide comparative drainage instructions. [9]A1c[10]A1c[11]A1c Definitive ureteroscopy or other stone treatment should be undertaken only after appropriate evaluation and management of infection risk. Postoperative infection remains a major concern: a multicenter study evaluated flexible, navigable suction ureteral access sheath-assisted retrograde intrarenal surgery under local anesthesia in patients with stones ≤30 mm and persistent asymptomatic bacteriuria or pyuria despite antibiotic therapy, specifically because infection limits retrograde intrarenal surgery and postoperative fever or sepsis are serious complications. [243]
Stone and urine microbiology may be discordant. In a retrospective PCNL cohort, stone cultures were positive in 56% of patients and polymicrobial in 25%; these findings support careful preoperative infection assessment and consideration of intraoperative stone cultures in high-risk procedures. [246] Reported post-ureteroscopy sepsis rates may also be inflated when based solely on administrative or billing codes; one study specifically compared coded events with clinically verified Sepsis-3 cases. [247]C Accordingly, postoperative fever, hypotension, altered mental status, or other systemic deterioration after instrumentation warrants prompt clinical reassessment rather than reliance on diagnostic coding or a single culture result. [246][247]C
Definitive treatment after stabilization
For selected renal stones, less invasive techniques may facilitate recovery. Prospective observational data evaluated total tubeless mini-PCNL for renal stones measuring 10–30 mm, while a randomized trial assessed tract infiltration with 20 mL of 0.25% bupivacaine after tubeless PCNL for solitary renal pelvic stones <3 cm to reduce postoperative pain. These studies address postoperative technique, not emergency decompression, and should not be used to delay drainage in an infected or obstructed system. [249][244]
Pre-stenting before retrograde intrarenal surgery has also been evaluated in a randomized trial assessing access-sheath insertion, operative time, stone-free status, and postoperative complications; the supplied abstract does not provide the comparative results. [140]A1b Novel suction-enabled ureteroscopy has real-world retrospective data from 61 cases involving 106 stones, but this evidence is insufficient to establish superiority over standard approaches in emergency obstruction. [93]C4
Follow-up and safety net
Discharge is appropriate only when the patient is clinically stable, pain and vomiting are controlled, renal function is acceptable, and there is a reliable plan for urologic follow-up and definitive stone management. Delays in follow-up can affect time to surgery and other outcomes; a diverse urban cohort specifically examined language-associated differences in follow-up after emergency-department renal-colic visits. [245] Patients should receive clear return precautions for fever, rigors, worsening pain, persistent vomiting, reduced urine output, or clinical deterioration because obstruction complicated by infection or AKI can become life-threatening. [136]A1a[227]C
| Clinical situation | Management implication |
|---|---|
| Suspected obstructing stone with infection or systemic illness | Urgent urologic assessment for drainage and antimicrobial management; defer definitive stone treatment until stabilization. [9]A1c[10]A1c[11]A1c[136]A1a[227]C |
| AKI, anuria, solitary-kidney obstruction, or progressive renal impairment | Treat as high risk and follow emergency-urology decompression protocols; no numeric timing threshold is provided in the supplied abstracts. [9]A1c[10]A1c[11]A1c[227]C |
| Stable renal colic without high-risk features | Provide protocolized analgesia, discharge education, and timely urologic follow-up. [137]B2b[251][245] |
| Persistent bacteriuria or pyuria before endoscopic treatment | Reassess infection risk and perioperative strategy; postoperative fever and sepsis are important complications. [243][246][247]C |
Definitive Management & Prevention
- ▸PCNL is the gold standard for stones >20 mm.
- ▸Potassium citrate reduces recurrence risk by 79% (high-level evidence).
Treatment choice depends on size: <10 mm (Observation/ESWL), 10-20 mm (URS/ESWL), >20 mm (PCNL) [110]A1a[111]A1a. In children, mini-PCNL is superior to ESWL (93% vs 33% SFR) [60]A1b. Medical prevention includes high fluid intake (urine output >2.5 L/d; RR 0.39) and (1 mEq/kg/day in peds) [62]A1a[165]A1a. Recent data (NOSTONE trial) showed no benefit for over placebo for recurrence [41]A1b. Pearl: For lower pole stones < 2 cm, active displacement to the upper pole during ureteroscopy significantly improves stone-free rates (RR 1.21) without increasing complications [99]A1a.
References
- [1]
Gambaro G, Croppi E, Coe F et al.. “Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement.” Journal of nephrology (2016). PMID: 27456839 ↗
L1GUIDELINECited in: Definition, Classification & Nomenclature - [2]
Elhaie M, Koozari A, Albeshan SM et al.. “Applications of artificial intelligence algorithms in ultrasound-based kidney stone detection, classification, prediction, and management: a systematic review.” Abdominal radiology (New York) (2026). PMID: 41801379 ↗
L5SR_OBSCited in: Definition, Classification & Nomenclature, Diagnosis & Workup, Endoscopic & Procedural Technique Considerations - [3]
Arroyave JS, Restrepo M, Cohen D et al.. “Appraisal of Spanish-language online patient education resources for kidney stones.” World journal of urology (2025). PMID: 40259134 ↗
L4OTHERCited in: Definition, Classification & Nomenclature - [4]
Szydełko T, Kasprzak J, Apoznański W et al.. “Clavien classification of complications after 150 laparoscopic pyeloplasties.” Urology (2011). PMID: 21316094 ↗
L4OTHERCited in: Definition, Classification & Nomenclature, Complications - [5]
Li KD, Pearce RJ, Sui W et al.. “Renal Autotransplantation: Association Between Preoperative Disease Duration and Surgical Outcomes.” Urology (2024). PMID: 38942394 ↗
L3OTHERCited in: Definition, Classification & Nomenclature - [6]
Hein S, Schoenthaler M, Wilhelm K et al.. “Ultralow Radiation Exposure During Flexible Ureteroscopy in Patients With Nephrolithiasis-How Far Can We Go?” Urology (2017). PMID: 28648966 ↗
L4OTHERCited in: Definition, Classification & Nomenclature - [7]
Lu S, Cottone CM, Yoon R et al.. “Endockscope: A Disruptive Endoscopic Technology.” Journal of endourology (2019). PMID: 31195831 ↗
L5OTHERCited in: Definition, Classification & Nomenclature - [8]
Borofsky MS, Dauw CA, Cohen A et al.. “Integration and utilization of modern technologies in nephrolithiasis research.” Nature reviews. Urology (2016). PMID: 27549355 ↗
L5REVIEW_NARRATIVECited in: Definition, Classification & Nomenclature - [9]
Pearle MS, Matlaga BR, Antonelli JA et al.. “Surgical Management of Kidney and Ureteral Stones: AUA Guideline (2026). Part III: Treatment of Patients With Kidney and/or Ureteral Stones and Future Directions.” The Journal of urology (2025). PMID: 41263325 ↗
L1GUIDELINECited in: Pathophysiology & Mechanism, Diagnosis & Workup, Acute Management & Decompression, Long-term & Definitive Management: Medical vs Endourologic/Surgical, History and Evolution of Treatment, Endoscopic & Procedural Technique Considerations, Special Populations & Pregnancy - [10]
Pearle MS, Matlaga BR, Antonelli JA et al.. “Surgical Management of Kidney and Ureteral Stones: AUA Guideline (2026) Part I: Evaluation and Treatment of Patients With Kidney and/or Ureteral Stones.” The Journal of urology (2025). PMID: 41263323 ↗
L1GUIDELINECited in: Pathophysiology & Mechanism, Diagnosis & Workup, Acute Management & Decompression, Long-term & Definitive Management: Medical vs Endourologic/Surgical, History and Evolution of Treatment, Endoscopic & Procedural Technique Considerations, Special Populations & Pregnancy - [11]
Pearle MS, Matlaga BR, Antonelli JA et al.. “Surgical Management of Kidney and Ureteral Stones: AUA Guideline (2026). Part II: Evaluation and Treatment of Patients With Kidney and/or Ureteral Stones.” The Journal of urology (2025). PMID: 41263322 ↗
L1GUIDELINECited in: Pathophysiology & Mechanism, Diagnosis & Workup, Acute Management & Decompression, Long-term & Definitive Management: Medical vs Endourologic/Surgical, History and Evolution of Treatment, Endoscopic & Procedural Technique Considerations, Special Populations & Pregnancy - [12]
Robinson MR, Norris RD, Sur RL et al.. “Urolithiasis: not just a 2-legged animal disease.” The Journal of urology (2007). PMID: 17997446 ↗
L5SR_OBSCited in: Pathophysiology & Mechanism - [13]
Pais VM, Smith RE, Stedina EA et al.. “Does Omission of Ureteral Stents Increase Risk of Unplanned Return Visit? A Systematic Review and Meta-Analysis.” The Journal of urology (2016). PMID: 27287523 ↗
L1SR_OBSCited in: Pathophysiology & Mechanism, Clinical Presentation - [14]
Tuo X, Ma Y, Ma Y et al.. “Intervention versus observation for asymptomatic kidney stones: a systematic review and meta-analysis of randomized controlled trials.” World journal of urology (2026). PMID: 42289039 ↗
L1SR_MA_RCTCited in: Pathophysiology & Mechanism, Diagnosis & Workup, Long-term & Definitive Management: Medical vs Endourologic/Surgical, Complications, Prognosis & Natural History, Prevention, Screening & Surveillance - [15]
Barghouthy Y, Corrales M, Doizi S et al.. “Tea and coffee consumption and pathophysiology related to kidney stone formation: a systematic review.” World journal of urology (2020). PMID: 33052484 ↗
L5SR_OBSCited in: Pathophysiology & Mechanism - [16]
Vezzoli G, Soldati L, Gambaro G. “Update on primary hypercalciuria from a genetic perspective.” The Journal of urology (2008). PMID: 18343451 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology & Mechanism - [17]
Su B, Ren Y, Yao W et al.. “Mitochondrial dysfunction and NLRP3 inflammasome: key players in kidney stone formation.” BJU international (2024). PMID: 38967108 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology & Mechanism, History and Evolution of Treatment - [18]
Watson G, Payne SR, Kunitsky K et al.. “Stone disease in low- and middle-income countries: could augmented reality have a role in its management?” BJU international (2022). PMID: 35993671 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology & Mechanism, Diagnosis & Workup, Long-term & Definitive Management: Medical vs Endourologic/Surgical, Endoscopic & Procedural Technique Considerations, Prognosis & Natural History, Special Populations & Pregnancy - [19]
Bhojani N, Koo KC, Bensaadi K et al.. “Retrospective first-in-human use of the LithoVue™ Elite ureteroscope to measure intrarenal pressure.” BJU international (2023). PMID: 37667553 ↗
L4OTHERCited in: Pathophysiology & Mechanism, Diagnosis & Workup, Long-term & Definitive Management: Medical vs Endourologic/Surgical, Endoscopic & Procedural Technique Considerations - [20]
Baccala A, Lee U, Hegarty N et al.. “Laparoscopic partial nephrectomy for tumour in the presence of nephrolithiasis or pelvi-ureteric junction obstruction.” BJU international (2008). PMID: 18990171 ↗
L4OTHERCited in: Pathophysiology & Mechanism - [21]
Boonla C, Hunapathed C, Bovornpadungkitti S et al.. “Messenger RNA expression of monocyte chemoattractant protein-1 and interleukin-6 in stone-containing kidneys.” BJU international (2008). PMID: 18241247 ↗
L4OTHERCited in: Pathophysiology & Mechanism - [22]
Miller NL, Williams JC, Evan AP et al.. “In idiopathic calcium oxalate stone-formers, unattached stones show evidence of having originated as attached stones on Randall's plaque.” BJU international (2009). PMID: 19549258 ↗
L4OTHERCited in: Pathophysiology & Mechanism, Long-term & Definitive Management: Medical vs Endourologic/Surgical - [23]
Moe OW. “Kidney stones: pathophysiology and medical management.” Lancet (London, England) (2006). PMID: 16443041 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology & Mechanism - [24]
Chait AR, Hassig S, Cubillos J et al.. “Cystinuria Complicated by Anuria From Bilateral Obstructing Stones Requiring Bilateral Mini Percutaneous Nephrolithotomy in a 22-Month-Old.” Urology (2024). PMID: 38281667 ↗
L4CASE_REPORTCited in: Pathophysiology & Mechanism, Clinical Presentation, Special Populations & Pregnancy - [25]
Beland LE, Henry MA, Solomon T et al.. “Obstructing Nephrolithiasis in an 84-year-old Patient With a Diaphragmatic Herniated Ureter.” Urology (2018). PMID: 30472257 ↗
L4CASE_REPORTCited in: Pathophysiology & Mechanism - [26]
Scotland KB, Kroczak T, Pace KT et al.. “Stone technology: intracorporeal lithotripters.” World journal of urology (2017). PMID: 28608192 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology & Mechanism, Long-term & Definitive Management: Medical vs Endourologic/Surgical, Endoscopic & Procedural Technique Considerations - [27]
Ergül RB, Ozervarli MF, Oba KC et al.. “Urinary tract anomalies and their role in pediatric stone formation.” World journal of urology (2025). PMID: 41083800 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology & Mechanism, Endoscopic & Procedural Technique Considerations, Special Populations & Pregnancy - [28]
İbis MA, Oktar A, Gokce MI. “Dietary advice for patients with bowel-related conditions and malabsorption.” World journal of urology (2023). PMID: 36648528 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology & Mechanism - [29]
Policastro C, Dispagna M, Smith G et al.. “Factors associated with unplanned clinical encounters for ureteral stent-related symptoms.” World journal of urology (2024). PMID: 38324162 ↗
L3OTHERCited in: Pathophysiology & Mechanism, Clinical Presentation, Acute Management & Decompression, History and Evolution of Treatment - [30]
Tasca A, Dalle Carbonare L, Nigro F et al.. “Bone disease in patients with primary hypercalciuria and calcium nephrolithiasis.” Urology (2009). PMID: 19428073 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology & Mechanism - [31]
Cohen AJ, Adamsky MA, Nottingham CU et al.. “Impact of Statin Intake on Kidney Stone Formation.” Urology (2018). PMID: 29421299 ↗
L3OTHERCited in: Pathophysiology & Mechanism - [32]
Yang Y, Wang Q, Xun Y et al.. “The Preliminary Exploration of What Role miRNAs Derived From Urinary Exosomes Play in Kidney Stone Formation.” Urology (2022). PMID: 35636636 ↗
L4OTHERCited in: Pathophysiology & Mechanism - [33]
Cobb KD, Gomella PT, DiBianco JM et al.. “Are Emergently Placed Nephrostomy Tubes Suitable for Subsequent Percutaneous Endoscopic Renal Surgery?” Urology (2019). PMID: 30658069 ↗
L3OTHERCited in: Pathophysiology & Mechanism - [34]
Turan I, Atar M, Eltan M et al.. “Targeting Hypercalciuria in SLC34A1-Related Disorders: Impact of Oral Phosphate Therapy and Novel Genetic Insights in Pediatric Case Series.” Calcified tissue international (2026). PMID: 41543768 ↗
L4CASE_REPORTCited in: Pathophysiology & Mechanism - [35]
Chen H, Huang Z, Chen G et al.. “Case Report: Maternal near-miss-recovery from refractory septic shock with multiple organ dysfunction secondary to acute pyelonephritis in pregnancy.” Frontiers in medicine (2025). PMID: 41451099 ↗
L4CASE_REPORTCited in: Pathophysiology & Mechanism - [36]
Kalik SA, Abate EG, Cusano NE. “Normocalcemic Primary Hyperparathyroidism: An Evolving Understanding.” Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists (2026). PMID: 42419589 ↗
L5REVIEW_NARRATIVECited in: Pathophysiology & Mechanism - [37]
Rattananinsruang P, Peerapen P, Phuangkham S et al.. “Unveiling potential natural promoters of calcium oxalate kidney stones in the urine via anion-exchange chromatography, crystal assays, and proteomics.” Molecular and cellular biochemistry (2026). PMID: 42418121 ↗
L4OTHERCited in: Pathophysiology & Mechanism - [38]
Lahane GP, Bhat A, Kulkarni O et al.. “Nesfatin-1 mitigates calcium oxalate nephropathy in mice through GPR12 receptor modulation and PKCα/NADPH oxidase pathway inhibition.” Life sciences (2026). PMID: 42335987 ↗
L5OTHERCited in: Pathophysiology & Mechanism - [39]
Sur RL, Shore N, L'Esperance J et al.. “Silodosin to facilitate passage of ureteral stones: a multi-institutional, randomized, double-blinded, placebo-controlled trial.” European urology (2014). PMID: 25465978 ↗
L1RCTCited in: Epidemiology, Etiology & Risk Factors, Diagnosis & Workup, Acute Management & Decompression, Long-term & Definitive Management: Medical vs Endourologic/Surgical, History and Evolution of Treatment, Prognosis & Natural History - [40]
Donaldson JF, Lardas M, Scrimgeour D et al.. “Systematic review and meta-analysis of the clinical effectiveness of shock wave lithotripsy, retrograde intrarenal surgery, and percutaneous nephrolithotomy for lower-pole renal stones.” European urology (2014). PMID: 25449204 ↗
L1SR_OBSCited in: Epidemiology, Etiology & Risk Factors, Diagnosis & Workup, Severity, Staging & Risk Stratification, Long-term & Definitive Management: Medical vs Endourologic/Surgical, Prognosis & Natural History - [41]
Dhayat NA, Bonny O, Roth B et al.. “Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence.” The New England journal of medicine (2023). PMID: 36856614 ↗
L1RCTCited in: Epidemiology, Etiology & Risk Factors, Long-term & Definitive Management: Medical vs Endourologic/Surgical, History and Evolution of Treatment, Complications, Prognosis & Natural History - [42]
Smith-Bindman R, Aubin C, Bailitz J et al.. “Ultrasonography versus computed tomography for suspected nephrolithiasis.” The New England journal of medicine (2014). PMID: 25229916 ↗
L1RCTCited in: Epidemiology, Etiology & Risk Factors, Diagnosis & Workup, Acute Management & Decompression, Long-term & Definitive Management: Medical vs Endourologic/Surgical, History and Evolution of Treatment - [43]
Tozsin A, Akdere H, Guven S et al.. “A systematic review on urolithiasis in children with neurological disorders.” World journal of urology (2024). PMID: 39522107 ↗
L3SR_OBSCited in: Epidemiology, Etiology & Risk Factors, Long-term & Definitive Management: Medical vs Endourologic/Surgical, Endoscopic & Procedural Technique Considerations, Special Populations & Pregnancy - [44]
Suarez Arbelaez MC, Monshine J, Porto JG et al.. “The emerging role of the urinary microbiome in benign noninfectious urological conditions: an up-to-date systematic review.” World journal of urology (2023). PMID: 37737900 ↗
L2SR_OBSCited in: Epidemiology, Etiology & Risk Factors, Complications - [45]
Policastro LJ, Saggi SJ, Goldfarb DS et al.. “Personalized Intervention in Monogenic Stone Formers.” The Journal of urology (2017). PMID: 29061541 ↗
L5REVIEW_NARRATIVECited in: Epidemiology, Etiology & Risk Factors, Diagnosis & Workup, History and Evolution of Treatment, Complications, Prognosis & Natural History, Special Populations & Pregnancy - [46]
Shoag JE, Patel N, Posada L et al.. “Kidney Stones and Risk of Narcotic Use.” The Journal of urology (2019). PMID: 30829133 ↗
L2OTHERCited in: Epidemiology, Etiology & Risk Factors, History and Evolution of Treatment - [47]
Tasian GE, Copelovitch L. “Evaluation and medical management of kidney stones in children.” The Journal of urology (2014). PMID: 24960469 ↗
L5REVIEW_NARRATIVECited in: Epidemiology, Etiology & Risk Factors, Diagnosis & Workup, Long-term & Definitive Management: Medical vs Endourologic/Surgical, History and Evolution of Treatment, Complications, Prognosis & Natural History - [48]
Tasian GE, Kabarriti AE, Kalmus A et al.. “Kidney Stone Recurrence among Children and Adolescents.” The Journal of urology (2016). PMID: 27521691 ↗
L2OTHERCited in: Epidemiology, Etiology & Risk Factors, Complications, Special Populations & Pregnancy - [49]
Shoag J, Halpern J, Goldfarb DS et al.. “Risk of chronic and end stage kidney disease in patients with nephrolithiasis.” The Journal of urology (2014). PMID: 24929140 ↗
L2OTHERCited in: Epidemiology, Etiology & Risk Factors - [50]
Askeland EJ, Arlen AM, Erickson BA et al.. “Urological manifestations of Duchenne muscular dystrophy.” The Journal of urology (2013). PMID: 23357214 ↗
L4OTHERCited in: Epidemiology, Etiology & Risk Factors - [51]
Fankhauser CD, Kranzbühler B, Poyet C et al.. “Long-term Adverse Effects of Extracorporeal Shock-wave Lithotripsy for Nephrolithiasis and Ureterolithiasis: A Systematic Review.” Urology (2015). PMID: 25917723 ↗
L1SR_OBSCited in: Epidemiology, Etiology & Risk Factors, Long-term & Definitive Management: Medical vs Endourologic/Surgical - [52]
Shojaei-Zarghani S, Safarpour AR, Askari H et al.. “Metabolic Syndrome and Nephrolithiasis; A Cross Sectional Population-based Study on the Baseline Data of the PERSIAN Kavar Cohort Study.” Urology (2022). PMID: 36435345 ↗
L3COHORTCited in: Epidemiology, Etiology & Risk Factors, History and Evolution of Treatment - [53]
Hsi RS, Kabagambe EK, Shu X et al.. “Race- and Sex-related Differences in Nephrolithiasis Risk Among Blacks and Whites in the Southern Community Cohort Study.” Urology (2018). PMID: 29753847 ↗
L2COHORTCited in: Epidemiology, Etiology & Risk Factors, History and Evolution of Treatment - [54]
Huang MM, Winoker JS, Allaf ME et al.. “Evidence-based quality and accuracy of YouTube videos about nephrolithiasis.” BJU international (2020). PMID: 32805761 ↗
L5OTHERCited in: Epidemiology, Etiology & Risk Factors, Clinical Presentation - [55]
Ganesan V, Chen WM, Jain R et al.. “Multiple sclerosis and nephrolithiasis: a matched-case comparative study.” BJU international (2017). PMID: 28220601 ↗
L3OTHERCited in: Epidemiology, Etiology & Risk Factors, Long-term & Definitive Management: Medical vs Endourologic/Surgical, History and Evolution of Treatment - [56]
Bagrodia A, Malcolm JB, Diblasio CJ et al.. “Variation in the incidence of and risk factors for the development of nephrolithiasis after radical or partial nephrectomy.” BJU international (2010). PMID: 20156212 ↗
L3OTHERCited in: Epidemiology, Etiology & Risk Factors, History and Evolution of Treatment - [57]
Chung SD, Liu SP, Keller JJ et al.. “Urinary calculi and an increased risk of stroke: a population-based follow-up study.” BJU international (2012). PMID: 22583934 ↗
L2OTHERCited in: Epidemiology, Etiology & Risk Factors, History and Evolution of Treatment - [58]
Lotan Y, Buendia Jiménez I, Lenoir-Wijnkoop I et al.. “Primary prevention of nephrolithiasis is cost-effective for a national healthcare system.” BJU international (2012). PMID: 22686216 ↗
L2OTHERCited in: Epidemiology, Etiology & Risk Factors, History and Evolution of Treatment, Special Populations & Pregnancy, Prevention, Screening & Surveillance - [59]
Eisner BH, Sheth S, Herrick B et al.. “The effects of ambient temperature, humidity and season of year on urine composition in patients with nephrolithiasis.” BJU international (2012). PMID: 22578009 ↗
L2OTHERCited in: Epidemiology, Etiology & Risk Factors - [60]
Alhefnawy MA, Selmy GI, Salah E et al.. “Mini-Percutaneous Nephrolithotomy vs Extracorporeal Shock Wave Lithotripsy for Management of Renal Stones in Pediatric Age Group Less Than 6 Years with Renal Stones Less Than 20 mm. A Prospective, Randomized Trial.” Journal of endourology (2026). PMID: 41814636 ↗
L1RCTCited in: Epidemiology, Etiology & Risk Factors, Diagnosis & Workup, Long-term & Definitive Management: Medical vs Endourologic/Surgical, History and Evolution of Treatment, Endoscopic & Procedural Technique Considerations, Complications, Prognosis & Natural History, Special Populations & Pregnancy - [61]
Ticinesi A, Nouvenne A, Ferraro PM et al.. “Idiopathic Calcium Nephrolithiasis and Hypovitaminosis D: A Case-control Study.” Urology (2015). PMID: 26494294 ↗
L3CASE_CONTROLCited in: Epidemiology, Etiology & Risk Factors, History and Evolution of Treatment - [62]
Kern A, Grimsby G, Mayo H et al.. “Medical and dietary interventions for preventing recurrent urinary stones in children.” The Cochrane database of systematic reviews (2017). PMID: 29117629 ↗
L1SR_OBSCited in: Epidemiology, Etiology & Risk Factors, Long-term & Definitive Management: Medical vs Endourologic/Surgical, Complications, Prognosis & Natural History, Prevention, Screening & Surveillance - [63]
Vosoughi F, Nikeghbali G, Yazdanmehr A et al.. “Lower Limb Fractures in Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis of Incidence, Biochemical Risk Factors, and Surgical Management.” Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists (2026). PMID: 42413661 ↗
L1SR_OBSCited in: Epidemiology, Etiology & Risk Factors - [64]
Yaseen T, Afzal MU, Alhamaidah MA et al.. “Pooled frequency of ceftriaxone-induced urolithiasis in pediatric patients: a systematic review and meta-analysis.” Pediatric nephrology (Berlin, Germany) (2026). PMID: 42262580 ↗
L1SR_OBSCited in: Epidemiology, Etiology & Risk Factors, Diagnosis & Workup, Special Populations & Pregnancy - [65]
Villanueva-Congote J, Marin-Urrego JC, Bakbak H et al.. “Association Between Ambient Temperature and Urolithiasis: A Systematic Review and Meta-analysis.” Current urology reports (2026). PMID: 42176144 ↗
L1SR_OBSCited in: Epidemiology, Etiology & Risk Factors, Diagnosis & Workup, Acute Management & Decompression - [66]
Kim SJ, Mock S, Stock JA. “Cystine nephrolithiasis.” Urology (2013). PMID: 23688378 ↗
L4CASE_REPORTCited in: Epidemiology, Etiology & Risk Factors, Diagnosis & Workup, Special Populations & Pregnancy - [67]
Li Z, Liu Y, Xu K et al.. “Association between oxidative balance score, genetic susceptibility and nephrolithiasis: a cohort study based on the UK Biobank.” European journal of nutrition (2026). PMID: 42371152 ↗
L2COHORTCited in: Epidemiology, Etiology & Risk Factors - [68]
Levin Iaina N, Elshami H, Asali M. “Risk Factors and Prediction of Acute Kidney Injury in Hospitalized Urology Patients: A Retrospective Cohort Study.” Journal of clinical medicine (2026). PMID: 42123226 ↗
L3COHORTCited in: Epidemiology, Etiology & Risk Factors - [69]
Kasabwala K, Borofsky M, Grove S et al.. “Association of stone surgery with patient-reported complications after spinal cord injury.” Neurourology and urodynamics (2022). PMID: 35114016 ↗
L2OTHERCited in: Epidemiology, Etiology & Risk Factors, History and Evolution of Treatment, Prevention, Screening & Surveillance - [70]
Sorokin I, Mamoulakis C, Miyazawa K et al.. “Epidemiology of stone disease across the world.” World journal of urology (2017). PMID: 28213860 ↗
L5REVIEW_NARRATIVECited in: Epidemiology, Etiology & Risk Factors - [71]
De Coninck V, Keller EX, Somani B et al.. “Complications of ureteroscopy: a complete overview.” World journal of urology (2019). PMID: 31748953 ↗
L1REVIEW_NARRATIVECited in: Epidemiology, Etiology & Risk Factors, Diagnosis & Workup, Acute Management & Decompression, Long-term & Definitive Management: Medical vs Endourologic/Surgical - [72]
Canvasser NE, Alken P, Lipkin M et al.. “The economics of stone disease.” World journal of urology (2017). PMID: 28108799 ↗
L5OTHERCited in: Epidemiology, Etiology & Risk Factors, Diagnosis & Workup, Acute Management & Decompression - [73]
He H, Lei X, Zou X et al.. “Unravelling new mechanisms of occurrence and recurrence in calcium nephrolithiasis: the role of epigenetics.” World journal of urology (2026). PMID: 41944902 ↗
L5REVIEW_NARRATIVECited in: Epidemiology, Etiology & Risk Factors - [74]
Wiseman O, Ventimiglia E, Doizi S et al.. “Effects of Silicone Hydrocoated Double Loop Ureteral Stent on Symptoms and Quality of Life in Patients Undergoing Flexible Ureteroscopy for Kidney Stone: A Randomized Multicenter Clinical Study.” The Journal of urology (2020). PMID: 32364838 ↗
L1RCTCited in: Clinical Presentation, Acute Management & Decompression - [75]
Sivalingam S, Streeper NM, Sehgal PD et al.. “Does Combination Therapy with Tamsulosin and Tolterodine Improve Ureteral Stent Discomfort Compared with Tamsulosin Alone? A Double-Blind, Randomized, Controlled Trial.” The Journal of urology (2015). PMID: 26393904 ↗
L1RCTCited in: Clinical Presentation - [76]
Wood LN, Markowitz MA, Parameshwar PS et al.. “Is it Safe to Reduce Water Intake in the Overactive Bladder Population? A Systematic Review.” The Journal of urology (2018). PMID: 29499207 ↗
L5SR_OBSCited in: Clinical Presentation, Complications, Prognosis & Natural History - [77]
Lovegrove CE, Geraghty RM, Yang B et al.. “Natural history of small asymptomatic kidney and residual stones over a long-term follow-up: systematic review over 25 years.” BJU international (2021). PMID: 34157218 ↗
L2SR_OBSCited in: Clinical Presentation, Diagnosis & Workup, Acute Management & Decompression, History and Evolution of Treatment, Prognosis & Natural History, Prevention, Screening & Surveillance - [78]
Syed JS, Khan A, Van-Ryn MG et al.. “Toradol to Reduce Ureteroscopy Symptoms Trial (TRUST).” Urology (2022). PMID: 35314184 ↗
L1RCTCited in: Clinical Presentation, Diagnosis & Workup, Long-term & Definitive Management: Medical vs Endourologic/Surgical, History and Evolution of Treatment, Endoscopic & Procedural Technique Considerations - [79]
Bhojani N, Wollin DA, El Tayeb MM et al.. “Prospective Multicenter Evaluation of Pain Before and After Removal of Nonobstructing Renal Calculi: A CoRE Initiative.” The Journal of urology (2023). PMID: 38100842 ↗
L2OTHERCited in: Clinical Presentation - [80]
Aksenov LI, Fairchild RJ, Kaplan SJ et al.. “Behavioral Economics in Urology: A Scoping Review.” The Journal of urology (2022). PMID: 35344397 ↗
L5REVIEW_NARRATIVECited in: Clinical Presentation, Complications - [81]
Haberal HB, Tonyali S, Piana A et al.. “Current Perspectives on Endourological Ex Vivo Stone Interventions in Kidney Transplantation: A Systematic Review.” Urology (2024). PMID: 38878828 ↗
L1SR_OBSCited in: Clinical Presentation, Diagnosis & Workup, Long-term & Definitive Management: Medical vs Endourologic/Surgical, Prognosis & Natural History - [82]
Carvalho M, Martin RL, Passos RC et al.. “Nephrectomy as a cause of chronic kidney disease in the treatment of urolithiasis: a case-control study.” World journal of urology (2012). PMID: 22373698 ↗
L3CASE_CONTROLCited in: Clinical Presentation, Special Populations & Pregnancy - [83]
Umekawa T, Iguchi M, Uemura H et al.. “Oxalate ions and calcium oxalate crystal-induced up-regulation of osteopontin and monocyte chemoattractant protein-1 in renal fibroblasts.” BJU international (2006). PMID: 16925768 ↗
L5OTHERCited in: Clinical Presentation - [84]
Boonla C, Krieglstein K, Bovornpadungkitti S et al.. “Fibrosis and evidence for epithelial-mesenchymal transition in the kidneys of patients with staghorn calculi.” BJU international (2011). PMID: 21410631 ↗
L3OTHERCited in: Clinical Presentation, Severity, Staging & Risk Stratification - [85]
Weinberg AE, Hazard FK, Hsieh MH. “A case of genitourinary Crohn's disease.” Urology (2012). PMID: 22999453 ↗
L4CASE_REPORTCited in: Clinical Presentation - [86]
Cochran D, Cook G, Rensing A et al.. “A Rare Case of T-Cell Lymphoma Presenting With Bilateral Nephrolithiasis and Acute Renal Failure.” Urology (2020). PMID: 32592766 ↗
L4CASE_REPORTCited in: Clinical Presentation - [87]
Chang CP, Wang SS, Wen MC et al.. “Mucinous adenocarcinoma of the renal pelvis masquerading as xanthogranulomatous pyelonephritis.” Urology (2013). PMID: 23622771 ↗
L4CASE_REPORTCited in: Clinical Presentation - [88]
Acar B, Inci Arikan F, Emeksiz S et al.. “Risk factors for nephrolithiasis in children.” World journal of urology (2008). PMID: 18810456 ↗
L4OTHERCited in: Clinical Presentation - [89]
Martínez-Quintana E, Rodríguez-González F. “Crystalluria in adolescent and adult patients with congenital heart disease.” World journal of urology (2023). PMID: 37552266 ↗
L3OTHERCited in: Clinical Presentation - [90]
Giulioni C, Castellani D, Somani BK et al.. “The efficacy of retrograde intra-renal surgery (RIRS) for lower pole stones: results from 2946 patients.” World journal of urology (2023). PMID: 36930255 ↗
L4OTHERCited in: Clinical Presentation - [91]
Ortolini M, Breu B, Masnada A et al.. “Prolonged preoperative double J stenting increases post-ureteroscopy infectious complications.” World journal of urology (2025). PMID: 41160126 ↗
L3OTHERCited in: Clinical Presentation - [92]
Jahrreiss V, Yurdakul O, Veser J et al.. “Effect of parathyroidectomy on stone recurrence in primary hyperparathyroidism : A systematic review.” Wiener klinische Wochenschrift (2026). PMID: 41874646 ↗
L1SR_OBSCited in: Clinical Presentation, History and Evolution of Treatment - [93]
Hansen NF, Khizir L, Lay AH et al.. “Real-world efficacy and safety of the CVAC 2.0 ureteroscope: results from a single-center retrospective study.” Urolithiasis (2026). PMID: 42417984 ↗
L4COHORTCited in: Clinical Presentation - [94]
Manfredi G, Turisani A, Piasentier A et al.. “A Case of Tumor-Induced Osteomalacia Masked by Parathyroid Carcinoma.” Journal of clinical medicine (2026). PMID: 42279228 ↗
L4CASE_REPORTCited in: Clinical Presentation - [95]
Della Valentina S, Pierotti L, Sardella C et al.. “Clinical and genetic insights into Autosomal Dominant Hypocalcemia type 1: a single-center case series including genotype-phenotype correlations, pregnancy outcomes, and novel CASR variants.” Journal of endocrinological investigation (2026). PMID: 42223909 ↗
L4CASE_REPORTCited in: Clinical Presentation, Special Populations & Pregnancy - [96]
Bey A. “Primary hyperparathyroidism in pregnancy successfully treated with microwave ablation: a case report.” Frontiers in medicine (2026). PMID: 41657575 ↗
L4CASE_REPORTCited in: Clinical Presentation, Special Populations & Pregnancy - [97]
Eid MT, de Mul A, Muresan-Vintila L et al.. “Enamel renal syndrome due to FAM20A mutations: challenging kidney management in view of nephrocalcinosis, hypophosphatemia and hypocalciuria.” Orphanet journal of rare diseases (2026). PMID: 41645214 ↗
L4CASE_REPORTCited in: Clinical Presentation - [98]
De Coninck V, Keller EX, Rodríguez-Monsalve M et al.. “Systematic review of ureteral access sheaths: facts and myths.” BJU international (2018). PMID: 29752769 ↗
L5SR_OBSCited in: Diagnosis & Workup, Long-term & Definitive Management: Medical vs Endourologic/Surgical, Endoscopic & Procedural Technique Considerations - [99]
Dingwall A, Leighton J, Luk A et al.. “Ureteroscopy and lasertripsy for lower pole stones <2 cm, in situ vs displacement? A systematic review and meta-analysis.” BJU international (2024). PMID: 39400510 ↗
L1SR_OBSCited in: Diagnosis & Workup, Severity, Staging & Risk Stratification, Long-term & Definitive Management: Medical vs Endourologic/Surgical, Endoscopic & Procedural Technique Considerations, Prognosis & Natural History - [100]
Wang HS, Panagides J, Cahill D et al.. “Dietary Risk Factors for Pediatric Kidney Stones: A Case-Control Study.” The Journal of urology (2022). PMID: 35377774 ↗
L3CASE_CONTROLCited in: Diagnosis & Workup, Special Populations & Pregnancy - [101]
Li Y, Yao Z, Zhou Z et al.. “Efficacy and safety of retrograde intrarenal surgery with a flexible and navigable suction sheath (FANS-RIRS) versus mini-percutaneous nephrolithotomy (mPCNL) for 2-3 cm renal stones: a systematic review and meta-analysis of randomized controlled trials.” World journal of urology (2026). PMID: 41817775 ↗
L1SR_MA_RCTCited in: Diagnosis & Workup, Long-term & Definitive Management: Medical vs Endourologic/Surgical, Prognosis & Natural History - [102]
Krajewski W, Nowak Ł, Tomczak W et al.. “Feasibility and safety of 6.3 Fr vs. 7.5 Fr digital disposable ureteroscopes in retrograde intrarenal surgery: a prospective randomised trial.” World journal of urology (2025). PMID: 40853384 ↗
L1RCTCited in: Diagnosis & Workup, History and Evolution of Treatment, Endoscopic & Procedural Technique Considerations, Complications - [103]
Saglam R, Muslumanoglu AY, Tokatlı Z et al.. “A new robot for flexible ureteroscopy: development and early clinical results (IDEAL stage 1-2b).” European urology (2014). PMID: 25059998 ↗
L4OTHERCited in: Diagnosis & Workup, Long-term & Definitive Management: Medical vs Endourologic/Surgical, Endoscopic & Procedural Technique Considerations, Prognosis & Natural History - [104]
Chen TT, Wang C, Ferrandino MN et al.. “Radiation Exposure during the Evaluation and Management of Nephrolithiasis.” The Journal of urology (2015). PMID: 26055822 ↗
L5REVIEW_NARRATIVECited in: Diagnosis & Workup, Long-term & Definitive Management: Medical vs Endourologic/Surgical, Endoscopic & Procedural Technique Considerations - [105]
Torricelli FC, De SK, Gebreselassie S et al.. “Dyslipidemia and kidney stone risk.” The Journal of urology (2013). PMID: 24055417 ↗
L3OTHERCited in: Diagnosis & Workup - [106]
Ganesan V, De S, Greene D et al.. “Accuracy of ultrasonography for renal stone detection and size determination: is it good enough for management decisions?” BJU international (2016). PMID: 27459091 ↗
L3OTHERCited in: Diagnosis & Workup - [107]
Iremashvili V, Li S, Best SL et al.. “Clinical and demographic predictors of repeat stone surgery.” BJU international (2019). PMID: 31166648 ↗
L3OTHERCited in: Diagnosis & Workup, Long-term & Definitive Management: Medical vs Endourologic/Surgical, History and Evolution of Treatment, Endoscopic & Procedural Technique Considerations, Complications, Prognosis & Natural History - [108]
Patel RM, Walia AS, Grohs E et al.. “Effect of positioning on ureteric stone retropulsion: 'gravity works'.” BJU international (2018). PMID: 30098120 ↗
L5OTHERCited in: Diagnosis & Workup, Long-term & Definitive Management: Medical vs Endourologic/Surgical, Endoscopic & Procedural Technique Considerations - [109]
Karim Z, Gérard B, Bakouh N et al.. “NHERF1 mutations and responsiveness of renal parathyroid hormone.” The New England journal of medicine (2008). PMID: 18784102 ↗
L3OTHERCited in: Diagnosis & Workup - [110]
Setthawong V, Srisubat A, Potisat S et al.. “Extracorporeal shock wave lithotripsy (ESWL) versus percutaneous nephrolithotomy (PCNL) or retrograde intrarenal surgery (RIRS) for kidney stones.” The Cochrane database of systematic reviews (2023). PMID: 37526261 ↗
L1SR_OBSCited in: Diagnosis & Workup, Long-term & Definitive Management: Medical vs Endourologic/Surgical, Endoscopic & Procedural Technique Considerations, Prognosis & Natural History - [111]
Terro K, Vanthoor J, Wiseman O. “Evaluation of outcomes in kidney stone management: stone-free rate vs. cost vs. quality of life: a systematic review from EAU endourology.” World journal of urology (2026). PMID: 42001348 ↗
L1SR_OBSCited in: Diagnosis & Workup, Long-term & Definitive Management: Medical vs Endourologic/Surgical, Endoscopic & Procedural Technique Considerations, Prognosis & Natural History - [112]
Machado Filho C, Lepine HL, Lima MCMDS et al.. “One Session or Two? A Meta-Analysis of Same-Session Versus Staged Bilateral Percutaneous Nephrolithotomy.” Journal of endourology (2026). PMID: 41810589 ↗
L1SR_OBSCited in: Diagnosis & Workup, Long-term & Definitive Management: Medical vs Endourologic/Surgical, Complications, Prognosis & Natural History - [113]
Rapoport MJ, Sadah AY. “Gas-containing renal stones.” Urology (2006). PMID: 17070381 ↗
L4CASE_REPORTCited in: Diagnosis & Workup - [114]
Schulz AE, Green BW, Gupta K et al.. “Management of large kidney stones in the geriatric population.” World journal of urology (2023). PMID: 36856833 ↗
L5REVIEW_NARRATIVECited in: Diagnosis & Workup, Long-term & Definitive Management: Medical vs Endourologic/Surgical, Prognosis & Natural History, Special Populations & Pregnancy - [115]
Kroczak T, Scotland KB, Chew B et al.. “Shockwave lithotripsy: techniques for improving outcomes.” World journal of urology (2017). PMID: 28608191 ↗
L5REVIEW_NARRATIVECited in: Diagnosis & Workup, Long-term & Definitive Management: Medical vs Endourologic/Surgical, Endoscopic & Procedural Technique Considerations - [116]
Patel RM, Jefferson FA, Owyong M et al.. “Characterization of intracalyceal pressure during ureteroscopy.” World journal of urology (2020). PMID: 32462302 ↗
L4OTHERCited in: Diagnosis & Workup - [117]
Sur RL, Krambeck AE, Large T et al.. “A Randomized Controlled Trial of Preoperative Prophylactic Antibiotics for Percutaneous Nephrolithotomy in Moderate to High Infectious Risk Population: A Report from the EDGE Consortium.” The Journal of urology (2020). PMID: 33369488 ↗
L1RCTCited in: Severity, Staging & Risk Stratification - [118]
Wong C, Xu P, Dean N et al.. “A prospective survey evaluating the visual quality of KARL STORZ fiberoptic, digital, and disposable flexible ureteroscopes.” World journal of urology (2025). PMID: 39937281 ↗
L1RCTCited in: Severity, Staging & Risk Stratification - [119]
La Rochelle JC, Coogan CL. “Urological manifestations of sarcoidosis.” The Journal of urology (2011). PMID: 22088341 ↗
L5REVIEW_NARRATIVECited in: Severity, Staging & Risk Stratification - [120]
DeFoor W, Jackson E, Schulte M et al.. “Calcium-to-Citrate Ratio Distinguishes Solitary and Recurrent Urinary Stone Forming Children.” The Journal of urology (2017). PMID: 28365270 ↗
L3OTHERCited in: Severity, Staging & Risk Stratification - [121]
Scheidt MJ, Hohenwalter EJ, Pinchot JW et al.. “ACR Appropriateness Criteria® Radiologic Management of Urinary Tract Obstruction.” Journal of the American College of Radiology : JACR (2020). PMID: 32370972 ↗
L1GUIDELINECited in: Severity, Staging & Risk Stratification - [122]
Dillman JR, Rigsby CK, Iyer RS et al.. “ACR Appropriateness Criteria® Hematuria-Child.” Journal of the American College of Radiology : JACR (2018). PMID: 29724430 ↗
L1GUIDELINECited in: Severity, Staging & Risk Stratification - [123]
Qaseem A, Dallas P, Forciea MA et al.. “Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians.” Annals of internal medicine (2014). PMID: 25364887 ↗
L1GUIDELINECited in: Severity, Staging & Risk Stratification - [124]
Chappidi MR, Kates M, Tosoian JJ et al.. “Evaluation of gender-based disparities in time from initial haematuria presentation to upper tract urothelial carcinoma diagnosis: analysis of a nationwide insurance claims database.” BJU international (2017). PMID: 28418183 ↗
L2OTHERCited in: Severity, Staging & Risk Stratification - [125]
Zieber L, Creiderman G, Krenawi M et al.. “A nomogram to predict "pure" vs. "mixed" uric acid urinary stones.” World journal of urology (2024). PMID: 39480595 ↗
L3OTHERCited in: Severity, Staging & Risk Stratification - [126]
Bajaj M, Yuan L, Holmes LC et al.. “Predictors of surgical intervention following initial surveillance for acute ureteric colic.” World journal of urology (2018). PMID: 29600333 ↗
L3OTHERCited in: Severity, Staging & Risk Stratification, Prevention, Screening & Surveillance - [127]
Golomb D, Confino I, Avda Y et al.. “Predictive value of family history of kidney stones for metabolic abnormalities and stone composition.” World journal of urology (2026). PMID: 42360497 ↗
L3OTHERCited in: Severity, Staging & Risk Stratification - [128]
Reisiger K, Vardi I, Yan Y et al.. “Pediatric nephrolithiasis: does treatment affect renal growth?” Urology (2007). PMID: 17572213 ↗
L3OTHERCited in: Severity, Staging & Risk Stratification, Prognosis & Natural History, Special Populations & Pregnancy - [129]
Assimos D, Krambeck A, Miller NL et al.. “Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I.” The Journal of urology (2016). PMID: 27238616 ↗
L1GUIDELINECited in: Acute Management & Decompression, Long-term & Definitive Management: Medical vs Endourologic/Surgical, History and Evolution of Treatment, Special Populations & Pregnancy - [130]
Assimos D, Krambeck A, Miller NL et al.. “Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART II.” The Journal of urology (2016). PMID: 27238615 ↗
L1GUIDELINECited in: Acute Management & Decompression, History and Evolution of Treatment, Special Populations & Pregnancy - [131]
Metzler IS, Smith-Bindman R, Moghadassi M et al.. “Emergency Department Imaging Modality Effect on Surgical Management of Nephrolithiasis: A Multicenter, Randomized Clinical Trial.” The Journal of urology (2016). PMID: 27773846 ↗
L1RCTCited in: Acute Management & Decompression - [132]
Demasi M, Segall M, Mengotto A et al.. “Optimizing pain management following kidney stone surgery: can we avoid narcotics?” World journal of urology (2022). PMID: 36371742 ↗
L1RCTCited in: Acute Management & Decompression, History and Evolution of Treatment - [133]
Barghouthy Y, Wiseman O, Ventimiglia E et al.. “Silicone-hydrocoated ureteral stents encrustation and biofilm formation after 3-week dwell time: results of a prospective randomized multicenter clinical study.” World journal of urology (2021). PMID: 33688992 ↗
L1RCTCited in: Acute Management & Decompression - [134]
Alexander CE, Gowland S, Cadwallader J et al.. “Shock wave lithotripsy (SWL): outcomes from a national SWL database in New Zealand.” BJU international (2016). PMID: 26923107 ↗
L2OTHERCited in: Acute Management & Decompression - [135]
Berger I, Wildhofen S, Lee A et al.. “Emergency nephrectomy due to severe urosepsis: a retrospective, multicentre analysis of 65 cases.” BJU international (2009). PMID: 19338556 ↗
L4OTHERCited in: Acute Management & Decompression - [136]
Asher GN, Viprakasit DP, Aymes SE et al.. “Prevention of Recurrent Nephrolithiasis in Adults and Children : A Systematic Review.” Annals of internal medicine (2026). PMID: 41871357 ↗
L1SR_OBSCited in: Acute Management & Decompression, Complications, Prognosis & Natural History, Prevention, Screening & Surveillance - [137]
Balen F, Cideron C, Noizet M et al.. “Predicting surgery within one week of emergency department presentation for renal colic using the CLAD-MB score: A prospective cohort study.” The American journal of emergency medicine (2025). PMID: 41175442 ↗
L2COHORTCited in: Acute Management & Decompression, History and Evolution of Treatment - [138]
Wollin DA, Joyce AD, Gupta M et al.. “Antibiotic use and the prevention and management of infectious complications in stone disease.” World journal of urology (2017). PMID: 28160088 ↗
L5REVIEW_NARRATIVECited in: Acute Management & Decompression - [139]
Eredics K, Drerup M, Özsoy M et al.. “Active stone removal is a safe option for ocotogenarians and nonagenarians with nephrolithiasis.” World journal of urology (2023). PMID: 36754879 ↗
L3OTHERCited in: Acute Management & Decompression - [140]
Ansari MI, Khan SA, Thakur DK et al.. “Comparative efficacy of pre-stented versus non-stented retrograde intrarenal surgery: A randomized controlled trial.” Medicine (2025). PMID: 40441236 ↗
L1RCTCited in: Acute Management & Decompression - [141]
Dai JC, Nicholson TM, Chang HC et al.. “Nephrolithiasis in Pregnancy: Treating for Two.” Urology (2020). PMID: 32866511 ↗
L5REVIEW_NARRATIVECited in: Acute Management & Decompression, Special Populations & Pregnancy - [142]
Roth JD, Pariser JJ, Stout TE et al.. “Presentation and Management Patterns of Lower Urinary Tract Symptoms in Adults Due to Rare Inherited Neuromuscular Diseases.” Urology (2019). PMID: 31626855 ↗
L4REVIEW_NARRATIVECited in: Acute Management & Decompression, Complications, Prognosis & Natural History - [143]
Raskolnikov D, Hall MK, Ngo SD et al.. “Strategies to Optimize Nephrolithiasis Emergency Care (STONE): Prospective Evaluation of an Emergency Department Clinical Pathway.” Urology (2021). PMID: 34757049 ↗
L2OTHERCited in: Acute Management & Decompression - [144]
Hsiang WR, Yousman L, Kim D et al.. “Access to Urologic Care at Urgent Care Centers.” Urology (2021). PMID: 34181971 ↗
L2OTHERCited in: Acute Management & Decompression, Endoscopic & Procedural Technique Considerations - [145]
DeWitt-Foy ME, Gao T, Schold J et al.. “Stones and Moans: Higher Number of Nephrolithiasis Related Encounters Increases the Odds of Opioid Misuse.” Urology (2021). PMID: 34653430 ↗
L3OTHERCited in: Acute Management & Decompression - [146]
Ziemba JB, Jones A, Lin G et al.. “Postoperative Recovery of Quality-of-Life Following Ureteroscopy for Nephrolithiasis: The Impact on Pain Intensity and Interference and the Ability to Participate in Social Roles.” Urology (2024). PMID: 38508532 ↗
L2OTHERCited in: Acute Management & Decompression - [147]
Lyon M, Sun A, Shah A et al.. “Comparison of Radiation Exposure for Pregnant Patients Requiring Intervention for Suspected Obstructing Nephrolithiasis.” Urology (2023). PMID: 37783398 ↗
L3OTHERCited in: Acute Management & Decompression, Special Populations & Pregnancy - [148]
Dean NS, Millan B, Uy M et al.. “Ureteral Wall Thickness Is an Effective Predictor of Ureteral Stone Impaction and Management Outcomes: A Systematic Review and Meta-analysis.” The Journal of urology (2023). PMID: 37232694 ↗
L1SR_OBSCited in: Long-term & Definitive Management: Medical vs Endourologic/Surgical, Prognosis & Natural History - [149]
Leder BZ, Tsai JN, Uihlein AV et al.. “Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.” Lancet (London, England) (2015). PMID: 26144908 ↗
L1RCTCited in: Long-term & Definitive Management: Medical vs Endourologic/Surgical, History and Evolution of Treatment - [150]
Baldea KG, Patel PM, Delos Santos G et al.. “Paravertebral block for percutaneous nephrolithotomy: a prospective, randomized, double-blind placebo-controlled study.” World journal of urology (2020). PMID: 31982963 ↗
L1RCTCited in: Long-term & Definitive Management: Medical vs Endourologic/Surgical - [151]
Higazy A, Kandil M, Elshafei A et al.. “Flexible mini-percutaneous nephrolithotomy versus retrograde intra-renal surgery in the management of renal stones: a randomized controlled trial.” World journal of urology (2025). PMID: 40418257 ↗
L1RCTCited in: Long-term & Definitive Management: Medical vs Endourologic/Surgical, History and Evolution of Treatment, Endoscopic & Procedural Technique Considerations, Prognosis & Natural History - [152]
El-Shaer W, Kandeel W, Abdel-Lateef S et al.. “Complete Ultrasound-guided Percutaneous Nephrolithotomy in Prone and Supine Positions: A Randomized Controlled Study.” Urology (2019). PMID: 30902696 ↗
L1RCTCited in: Long-term & Definitive Management: Medical vs Endourologic/Surgical, History and Evolution of Treatment - [153]
Davis NF, Quinlan MR, Poyet C et al.. “Miniaturised percutaneous nephrolithotomy versus flexible ureteropyeloscopy: a systematic review and meta-analysis comparing clinical efficacy and safety profile.” World journal of urology (2018). PMID: 29450733 ↗
L1SR_OBSCited in: Long-term & Definitive Management: Medical vs Endourologic/Surgical, Endoscopic & Procedural Technique Considerations, Prognosis & Natural History - [154]
Talyshinskii A, Juliebø-Jones P, Tzelves L et al.. “Current state of AI for shockwave lithotripsy: a systematic review from YAU and EAU endourology.” World journal of urology (2025). PMID: 40643681 ↗
L5SR_OBSCited in: Long-term & Definitive Management: Medical vs Endourologic/Surgical - [155]
Zilberman DE, Lipkin ME, de la Rosette JJ et al.. “Tubeless percutaneous nephrolithotomy--the new standard of care?” The Journal of urology (2010). PMID: 20723920 ↗
L5REVIEW_NARRATIVECited in: Long-term & Definitive Management: Medical vs Endourologic/Surgical, Endoscopic & Procedural Technique Considerations - [156]
DiBianco JM, Daignault-Newton S, Fernandez Moncaleano G et al.. “Ureteroscopy vs Shock Wave Lithotripsy for Lower Pole Renal Stones: Treatment Variation and Outcomes in a Surgical Collaborative.” The Journal of urology (2025). PMID: 40489579 ↗
L3OTHERCited in: Long-term & Definitive Management: Medical vs Endourologic/Surgical - [157]
Bloom J, Matthews G, Phillips J. “Factors Influencing Readmission after Elective Ureteroscopy.” The Journal of urology (2015). PMID: 26602889 ↗
L4OTHERCited in: Long-term & Definitive Management: Medical vs Endourologic/Surgical, History and Evolution of Treatment, Endoscopic & Procedural Technique Considerations - [158]
Smaldone MC, Corcoran AT, Docimo SG et al.. “Endourological management of pediatric stone disease: present status.” The Journal of urology (2008). PMID: 19012920 ↗
L5REVIEW_NARRATIVECited in: Long-term & Definitive Management: Medical vs Endourologic/Surgical, Endoscopic & Procedural Technique Considerations - [159]
Ziemba JB, Matlaga BR. “Guideline of guidelines: kidney stones.” BJU international (2015). PMID: 25684222 ↗
L1OTHERCited in: Long-term & Definitive Management: Medical vs Endourologic/Surgical, Complications, Prognosis & Natural History - [160]
Ganpule A, Chhabra JS, Kore V et al.. “Factors predicting outcomes of micropercutaneous nephrolithotomy: results from a large single-centre experience.” BJU international (2015). PMID: 26331966 ↗
L4OTHERCited in: Long-term & Definitive Management: Medical vs Endourologic/Surgical, Endoscopic & Procedural Technique Considerations - [161]
Randell RL, Maharaj A, Laughon M et al.. “Population Pharmacokinetics and Exposure-Safety Analysis of Furosemide in Preterm Infants.” Journal of clinical pharmacology (2026). PMID: 42003090 ↗
L2RCTCited in: Long-term & Definitive Management: Medical vs Endourologic/Surgical, History and Evolution of Treatment, Special Populations & Pregnancy - [162]
Talyshinskii A, Khairley G, Tur AB et al.. “Role of pediatric ureteroscopy for large renal stones: a systematic review and meta-analysis from EAU endourology.” World journal of urology (2025). PMID: 41176750 ↗
L1SR_OBSCited in: Long-term & Definitive Management: Medical vs Endourologic/Surgical, Complications, Special Populations & Pregnancy - [163]
Jung M, Rai A, Wang L et al.. “Nephrolithiasis in a 17-Year-Old Male With Seckel Syndrome and Horseshoe Kidneys: Case Report and Review of the Literature.” Urology (2018). PMID: 29894776 ↗
L4CASE_REPORTCited in: Long-term & Definitive Management: Medical vs Endourologic/Surgical, History and Evolution of Treatment, Endoscopic & Procedural Technique Considerations - [164]
Pearle MS, Goldfarb DS, Assimos DG et al.. “Medical management of kidney stones: AUA guideline.” The Journal of urology (2014). PMID: 24857648 ↗
L1GUIDELINECited in: History and Evolution of Treatment, Complications, Prognosis & Natural History - [165]
Fink HA, Akornor JW, Garimella PS et al.. “Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials.” European urology (2009). PMID: 19321253 ↗
L1SR_OBSCited in: History and Evolution of Treatment, Complications, Prognosis & Natural History, Prevention, Screening & Surveillance - [166]
Brain E, Geraghty RM, Lovegrove CE et al.. “Natural History of Post-Treatment Kidney Stone Fragments: A Systematic Review and Meta-Analysis.” The Journal of urology (2021). PMID: 33904756 ↗
L1SR_OBSCited in: History and Evolution of Treatment, Prognosis & Natural History - [167]
Williams JJ, Rodman JS, Peterson CM. “A randomized double-blind study of acetohydroxamic acid in struvite nephrolithiasis.” The New England journal of medicine (1984). PMID: 6472365 ↗
L1RCTCited in: History and Evolution of Treatment - [168]
Lu P, Chen K, Wang Z et al.. “Clinical efficacy and safety of flexible ureteroscopic lithotripsy using 365 μm holmium laser for nephrolithiasis: a prospective, randomized, controlled trial.” World journal of urology (2019). PMID: 31030229 ↗
L1RCTCited in: History and Evolution of Treatment - [169]
Ozkaya O, Söylemezoğlu O, Misirlioğlu M et al.. “Polymorphisms in the vitamin D receptor gene and the risk of calcium nephrolithiasis in children.” European urology (2003). PMID: 12814692 ↗
L3OTHERCited in: History and Evolution of Treatment - [170]
Pagano F, Tasca A, Oliva G. “The evolution of renal function after surgical treatment of malignant lithiasis with severely compromised renal function.” European urology (1982). PMID: 7060603 ↗
L4OTHERCited in: History and Evolution of Treatment - [171]
Donsimoni R, Hennequin C, Fellahi S et al.. “New aspects of urolithiasis in France. GERBAP: Groupe d'Evaluation et de Recherche des Biologistes de l'Assistance Publique des Hôpitaux de Paris.” European urology (1997). PMID: 9032529 ↗
L2OTHERCited in: History and Evolution of Treatment - [172]
Taylor EN, Chan AT, Giovannucci EL et al.. “Cholelithiasis and the risk of nephrolithiasis.” The Journal of urology (2011). PMID: 21944091 ↗
L2OTHERCited in: History and Evolution of Treatment - [173]
Krautschick A, Esen T. “The role of the papilla in idiopathic calcium oxalate nephrolithiasis.” World journal of urology (1997). PMID: 9280049 ↗
L5REVIEW_NARRATIVECited in: History and Evolution of Treatment - [174]
Srirangapatanam S, Wiener S, Stoller ML. “Role of core body temperature in nephrolithiasis.” BJU international (2020). PMID: 32750202 ↗
L3OTHERCited in: History and Evolution of Treatment - [175]
Parr JM, Desai D, Winkle D. “Natural history and quality of life in patients with cystine urolithiasis: a single centre study.” BJU international (2015). PMID: 26204884 ↗
L4OTHERCited in: History and Evolution of Treatment - [176]
Penniston KL, Jones AN, Nakada SY et al.. “Vitamin D repletion does not alter urinary calcium excretion in healthy postmenopausal women.” BJU international (2009). PMID: 19389005 ↗
L2OTHERCited in: History and Evolution of Treatment - [177]
Baggio B, Gambaro G, Marchini F et al.. “An inheritable anomaly of red-cell oxalate transport in "primary" calcium nephrolithiasis correctable with diuretics.” The New England journal of medicine (1986). PMID: 3945245 ↗
L3OTHERCited in: History and Evolution of Treatment - [178]
Husmann DA, Pappas TN, Preminger GM. “Nephrolithiasis on the National Stage: The Kidney Stones of President Lyndon B. Johnson.” Urology (2024). PMID: 39293672 ↗
L5REVIEW_NARRATIVECited in: History and Evolution of Treatment, Endoscopic & Procedural Technique Considerations - [179]
Bhan A, Simon R, Yaseen A et al.. “The predictive value of 24-hour urinary calcium for kidney stone risk in primary hyperparathyroidism: insight from a retrospective study of parathyroid adenoma cases.” Frontiers in endocrinology (2025). PMID: 41377934 ↗
L3COHORTCited in: History and Evolution of Treatment - [180]
Lieske JC, Groothoff JW, Frishberg Y et al.. “Natural History of Advanced Primary Hyperoxaluria Type 1: A Retrospective Study.” Kidney medicine (2025). PMID: 41209157 ↗
L3COHORTCited in: History and Evolution of Treatment - [181]
Qi H, Chen H, Dalbeth N et al.. “Two-decade trajectories of gout: a multicentre cohort study of 10 658 Chinese patients with gout.” Rheumatology (Oxford, England) (2026). PMID: 41137675 ↗
L2COHORTCited in: History and Evolution of Treatment - [182]
Liu N, Feng Y, Li J et al.. “Relationship between the dietary inflammatory index and kidney stone prevalence.” World journal of urology (2022). PMID: 35396944 ↗
L2OTHERCited in: History and Evolution of Treatment - [183]
Green BW, Labagnara K, Macdonald E et al.. “Evaluating the association between food insecurity and risk of nephrolithiasis: an analysis of the National Health and Nutrition Examination Survey.” World journal of urology (2022). PMID: 36125503 ↗
L2OTHERCited in: History and Evolution of Treatment - [184]
Ricapito A, Gupta K, Zipkin J et al.. “Comparison of metabolic parameters between pure-uric acid and mixed-uric acid kidney stone formers.” World journal of urology (2024). PMID: 38478092 ↗
L3OTHERCited in: History and Evolution of Treatment - [185]
Cotta BH, Nguyen V, Sur RL et al.. “Opiates prescribed for acute renal colic are associated with prolonged use.” World journal of urology (2020). PMID: 32740804 ↗
L3OTHERCited in: History and Evolution of Treatment - [186]
Liu CJ, Li WH, Li CH et al.. “Nephrolithiasis is associated with the severity of coronary artery calcification, but not with coronary artery stenosis.” World journal of urology (2023). PMID: 37284843 ↗
L3OTHERCited in: History and Evolution of Treatment - [187]
Gridley CM, Sourial MW, Lehman A et al.. “Medical dissolution therapy for the treatment of uric acid nephrolithiasis.” World journal of urology (2019). PMID: 30810833 ↗
L4OTHERCited in: History and Evolution of Treatment - [188]
Ganesan C, Frassetto L, Pao AC. “Nephrolithiasis: A Paleolithic Perspective and Physiological Approach to Prevention.” Annual review of medicine (2026). PMID: 41592925 ↗
L5REVIEW_NARRATIVECited in: History and Evolution of Treatment - [189]
Bacchetta J, Acquaviva-Bourdain C, Abid N et al.. “Primary hyperoxaluria(s): from trials to real-life data and pipeline therapies.” Kidney international (2026). PMID: 41579959 ↗
L5REVIEW_NARRATIVECited in: History and Evolution of Treatment - [190]
Abukhalil M, Mehjez O, Aladdam M et al.. “The radiological evaluation process of the potential live kidney donor assessment programme at al-Shifa Hospital: study and clinical audit.” Lancet (London, England) (2018). PMID: 29553430 ↗
L4OTHERCited in: Endoscopic & Procedural Technique Considerations - [191]
Moon H, Kim YC, Park HC et al.. “Association between nephrolithiasis and kidney disease progression in patients with autosomal dominant polycystic kidney disease: a prospective cohort study.” Clinical kidney journal (2026). PMID: 42428517 ↗
L2COHORTCited in: Endoscopic & Procedural Technique Considerations - [192]
Wymer KM, Boddu SP, Choudry M et al.. “Access to Care and Health Care Utilization Among Patients With Nephrolithiasis.” Urology (2024). PMID: 38432429 ↗
L3OTHERCited in: Endoscopic & Procedural Technique Considerations - [193]
Burns ZR, Sawyer KN, Selph JP. “Appendiceal Interposition for Ureteral Stricture Disease: Technique and Surgical Outcomes.” Urology (2020). PMID: 32961223 ↗
L4OTHERCited in: Endoscopic & Procedural Technique Considerations, Complications - [194]
Miernik A, Wilhelm K, Ardelt PU et al.. “Standardized flexible ureteroscopic technique to improve stone-free rates.” Urology (2012). PMID: 23206763 ↗
L4OTHERCited in: Endoscopic & Procedural Technique Considerations - [195]
Oliveira AV, Sampaio ALN, Mascarenhas RW et al.. “Thiazide and thiazide-like diuretics for kidney stones recurrence: a systematic review and network meta-analysis of randomised controlled trials.” World journal of urology (2025). PMID: 41396435 ↗
L1SR_MA_RCTCited in: Complications, Prognosis & Natural History, Prevention, Screening & Surveillance - [196]
Andrade MA, Godinho NJS, de Amorim LGCR et al.. “Single-session bilateral vs. staged unilateral renal stone removal: comparative outcomes in a systematic review and meta-analysis.” World journal of urology (2025). PMID: 41021030 ↗
L1SR_OBSCited in: Complications - [197]
Garbens A, Pearle MS. “Causes and prevention of kidney stones: separating myth from fact.” BJU international (2021). PMID: 34192414 ↗
L5REVIEW_NARRATIVECited in: Complications, Prognosis & Natural History - [198]
Worcester EM, Coe FL, Evan AP et al.. “Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis.” BJU international (2006). PMID: 16686727 ↗
L3OTHERCited in: Complications - [199]
Yang JYC, Sarwal RD, Ky K et al.. “Non-radiological assessment of kidney stones using the kidney injury test (KIT), a spot urine assay.” BJU international (2020). PMID: 31869527 ↗
L3OTHERCited in: Complications - [200]
Sui W, Yang H, Velasquez MC et al.. “Re-defining the interpretation of 24-h urine studies for stone formers.” BJU international (2025). PMID: 39846125 ↗
L3OTHERCited in: Complications - [201]
Freise J, Nunez M, Chi T et al.. “Therapeutic Living Donor Nephrectomy for Proximal Ureteral Pathology: A Longitudinal Case Series.” Urology (2022). PMID: 35550384 ↗
L4CASE_REPORTCited in: Complications, Prognosis & Natural History - [202]
Svihra J, Sopilko I, Blichova T et al.. “The comparison of synchronous bilateral and unilateral percutaneous nephrolithotomy: Meta-analysis.” Central European journal of urology (2026). PMID: 42375725 ↗
L1SR_OBSCited in: Complications - [203]
Sui W, Hancock J, Asplin JR et al.. “Nephrolithiasis and Elevated Urinary Ammonium: A Matched Comparative Study.” Urology (2020). PMID: 32544550 ↗
L3OTHERCited in: Complications, Prognosis & Natural History - [204]
Turner EN, Talwar R, Familusi OO et al.. “Race/Ethnicity and Insurance's Impact on Delays to Kidney Stone Surgery Scheduling.” Urology (2022). PMID: 35469809 ↗
L3OTHERCited in: Complications - [205]
Anderson A, Singh JA. “Pegloticase for chronic gout.” The Cochrane database of systematic reviews (2010). PMID: 20238366 ↗
L1SR_OBSCited in: Prognosis & Natural History - [206]
Bjelakovic G, Gluud LL, Nikolova D et al.. “Vitamin D supplementation for prevention of mortality in adults.” The Cochrane database of systematic reviews (2011). PMID: 21735411 ↗
L1SR_OBSCited in: Prognosis & Natural History, Special Populations & Pregnancy - [207]
Bjelakovic G, Gluud LL, Nikolova D et al.. “Vitamin D supplementation for prevention of cancer in adults.” The Cochrane database of systematic reviews (2014). PMID: 24953955 ↗
L1SR_OBSCited in: Prognosis & Natural History, Special Populations & Pregnancy - [208]
Bjelakovic G, Gluud LL, Nikolova D et al.. “Vitamin D supplementation for prevention of mortality in adults.” The Cochrane database of systematic reviews (2014). PMID: 24414552 ↗
L1SR_OBSCited in: Prognosis & Natural History, Special Populations & Pregnancy - [209]
Bevill M, Kattula A, Cooper CS et al.. “The Modern Metabolic Stone Evaluation in Children.” Urology (2016). PMID: 27838366 ↗
L4OTHERCited in: Prognosis & Natural History, Special Populations & Pregnancy - [210]
Simsekoglu MF, Ozman O, Sahin MF et al.. “Outcomes of retrograde intrarenal surgery in patients on anticoagulant or antiplatelet therapy: a multicenter matched case-control study by the RIRSearch Study Group.” World journal of urology (2025). PMID: 41148357 ↗
L3CASE_CONTROLCited in: Special Populations & Pregnancy - [211]
Tong CMC, Bicknell BT, Ellison JS et al.. “Influence of a Prospective Multicenter Clinical Trial on Adherence to Imaging Acquisition and Office Visit Follow-Up After Kidney Stone Surgery: A Bi-Institutional Experience.” Journal of endourology (2026). PMID: 42051168 ↗
L3TRIAL_NONRANDOMCited in: Special Populations & Pregnancy - [212]
Jha V, Venkateswarlu M, Shaharyar A et al.. “Thiazide therapy in chronic hypoparathyroidism: effects on hypercalciuria and renal function-a systematic review and exploratory meta-analysis.” Journal of endocrinological investigation (2026). PMID: 42287530 ↗
L1SR_OBSCited in: Special Populations & Pregnancy - [213]
Mazumder H, Gain EP, Shimul MH et al.. “Ambient Temperature and Risk of Renal Colic: A Systematic Review and Meta-analysis.” Kidney medicine (2025). PMID: 41531667 ↗
L2SR_OBSCited in: Special Populations & Pregnancy - [214]
Rosenberg E, Sergienko R, Abu-Ghanem S et al.. “Nephrolithiasis during pregnancy: characteristics, complications, and pregnancy outcome.” World journal of urology (2011). PMID: 21691721 ↗
L3OTHERCited in: Special Populations & Pregnancy - [215]
Khargi R, Blake RM, Yaghoubian AJ et al.. “Drivers of calcium oxalate stone formation in the octogenarian population.” World journal of urology (2023). PMID: 37847263 ↗
L4OTHERCited in: Special Populations & Pregnancy - [216]
Lee AS, McGarry L, Bowen DK et al.. “Patient Characteristics Associated With Completion of 24-hour Urine Analyses Among Children and Adolescents With Nephrolithiasis.” Urology (2019). PMID: 30796989 ↗
L2OTHERCited in: Special Populations & Pregnancy - [217]
Abedali ZA, Large T, Heiman JM et al.. “Percutaneous Nephrolithotomy in the 80 Years of Age and Older Population.” Urology (2019). PMID: 31536740 ↗
L3OTHERCited in: Special Populations & Pregnancy - [218]
Lotan Y, Pearle MS. “Cost-effectiveness of primary prevention strategies for nephrolithiasis.” The Journal of urology (2011). PMID: 21683379 ↗
L2OTHERCited in: Prevention, Screening & Surveillance - [219]
Milose JC, Kaufman SR, Hollenbeck BK et al.. “Prevalence of 24-hour urine collection in high risk stone formers.” The Journal of urology (2013). PMID: 24018242 ↗
L2OTHERCited in: Prevention, Screening & Surveillance - [220]
Veronese N, Ciriminna S, Errera CM et al.. “Preventing and treating kidney stones: an umbrella review of meta-analyses of non-surgical randomized controlled trials.” Minerva urology and nephrology (2025). PMID: 40891477 ↗
L1SR_MA_RCTCited in: Prevention, Screening & Surveillance - [221]
Porto BC, Terada BD, Gonçalves FG et al.. “Thiazide diuretics for preventing calcium oxalate recurrent kidney stones: an updated systematic review, meta-analysis and trial sequential analysis of randomized controlled trials.” Minerva urology and nephrology (2025). PMID: 40528770 ↗
L1SR_MA_RCTCited in: Prevention, Screening & Surveillance - [222]
Boissier R, Rodriguez-Faba O, Zakri RH et al.. “Evaluation of the Effectiveness of Interventions on Nephrolithiasis in Transplanted Kidney.” European urology focus (2022). PMID: 36567234 ↗
L1SR_OBSCited in: Prevention, Screening & Surveillance - [223]
Anagnostis P, Vaitsi K, Veneti S et al.. “Efficacy of parathyroidectomy compared with active surveillance in patients with mild asymptomatic primary hyperparathyroidism: a systematic review and meta-analysis of randomized-controlled studies.” Journal of endocrinological investigation (2020). PMID: 33074457 ↗
L1SR_OBSCited in: Prevention, Screening & Surveillance - [224]
Sui W, Gupta L, Azzawi AS et al.. “The association between quality of life, intensity of counseling and health literacy amongst patients with nephrolithiasis.” World journal of urology (2026). PMID: 41843185 ↗
L4OTHERCited in: Prevention, Screening & Surveillance - [225]
Patel SR, Wells S, Ruma J et al.. “Automated volumetric assessment by noncontrast computed tomography in the surveillance of nephrolithiasis.” Urology (2012). PMID: 22578829 ↗
L3OTHERCited in: Prevention, Screening & Surveillance - [226]
Bernard J, Song L, Henderson B et al.. “Association Between Daily Water Intake and 24-hour Urine Volume Among Adolescents With Kidney Stones.” Urology (2020). PMID: 32004558 ↗
L4OTHERCited in: Prevention, Screening & Surveillance - [227]
Rothner A, Fishberg SE, Hinden L et al.. “Endocannabinoid responses to relief of obstruction in acute injured kidney: a prospective observational study.” Therapeutic advances in urology (2026). PMID: 42027800 ↗
L4Cited in: Pathophysiology & Mechanism - [228]
Naik N, Cumming C, Bena J et al.. “Symptomatic Benign Prostate Hyperplasia May Increase the Risk of Kidney Stones.” Journal of endourology (2026). PMID: 42187164 ↗
L3bCited in: Pathophysiology & Mechanism - [229]
M'rad R, Kammoun M, Achour A et al.. “Clinical and molecular spectrum of primary hyperoxaluria type 1 in Tunisia: pediatric presentation and minimum observed prevalence.” Pediatric nephrology (Berlin, Germany) (2026). PMID: 42002641 ↗
L4Cited in: Pathophysiology & Mechanism - [230]
Yang EM, Ahn YH, Kim JH et al.. “Clinical characteristics and genetic analyses of Korean children with Dent disease.” Pediatric nephrology (Berlin, Germany) (2026). PMID: 42000952 ↗
L4Cited in: Pathophysiology & Mechanism - [231]
Peng L, Zhou X, Liu J et al.. “Analysis of 33,616 urinary stone cases: novel findings on renal transplantation impact, comorbidity profiles, and composition patterns.” Frontiers in immunology (2026). PMID: 41939899 ↗
L3bCited in: Pathophysiology & Mechanism - [232]
Hu X, Miao J, Huang Y et al.. “Urinary Diversion-Specific Morbidity After Radical Cystectomy: A Ten-Year Institutional Experience.” Cancer medicine (2026). PMID: 41833997 ↗
L3bCited in: Pathophysiology & Mechanism - [233]
Zhang P, Liu Y, Su B et al.. “Machine learning-driven multi-omics integration of urinary organic acids and ions enables precision risk stratification for calcium oxalate nephrolithiasis.” Frontiers in medicine (2026). PMID: 42089077 ↗
L3bCited in: Pathophysiology & Mechanism - [234]
Hengtrakul N, Furrow E, Toth F et al.. “Co-occurrence of nephrocalcinosis and nephrolithiasis in feline kidneys.” Journal of veterinary internal medicine (2026). PMID: 42149680 ↗
L3bCited in: Pathophysiology & Mechanism - [235]
Li G, Yao J, Yi X et al.. “Glyphosate promotes calcium oxalate crystal-induced renal injury by modulating the PI3K/Akt-mediated mechanism.” Ecotoxicology and environmental safety (2026). PMID: 41797104 ↗
L3bCited in: Pathophysiology & Mechanism - [236]
Lyu P, Yoo KW, Chen Z et al.. “Database of CLCN5 Pathogenic Variants Causing Dent Disease.” Kidney international reports (2026). PMID: 42006202 ↗
L4Cited in: Pathophysiology & Mechanism - [237]
Yan X, Li G, Wang Z et al.. “Serine mediates protection against calcium oxalate nephrolithiasis by attenuating tubular epithelial cell apoptosis through the SDSL-IDH2 axis.” International immunopharmacology (2026). PMID: 41930872 ↗
L3bCited in: Pathophysiology & Mechanism - [238]
Lovegrove CE, Geraghty R, Ahmad I et al.. “Trends in kidney stone disease: a 5-year update of stone management in England and Scotland.” BJU international (2026). PMID: 42581823 ↗
L5Cited in: Pathophysiology & Mechanism - [239]
Finegan JL, Katz JE, Berger JH et al.. “Does Continuous Intrarenal Pressure Predict Post-Ureteroscopy Sepsis? A Novel Pilot Study.” Journal of endourology (2026). PMID: 42548159 ↗
L5Cited in: Pathophysiology & Mechanism - [240]
Chen CY, Lee S, Lin CM et al.. “Genetic Susceptibility to Nephrolithiasis: A Genome-Phenome Approach with Polygenic Risk Score Analysis.” Kidney diseases (Basel, Switzerland) (2026). PMID: 42541249 ↗
L5Cited in: Pathophysiology & Mechanism - [241]
Wu H, Lin A, Chi J et al.. “Extraintestinal Manifestations of Inflammatory Bowel Disease: A Focus on Kidney Complications.” International journal of molecular sciences (2026). PMID: 42196598 ↗
L5Cited in: Pathophysiology & Mechanism - [242]
Giridharan S, Vasudevan V, Nanda Kumar SK et al.. “Targeting the Highly Deleterious G161C and Y260C SNP Variants of the AGXT Protein Involved in Glyoxylate Metabolism Using Tauroursodeoxycholic Acid: A Computational Study.” International journal of molecular sciences (2026). PMID: 42196567 ↗
L5Cited in: Pathophysiology & Mechanism - [243]
Zhang G, Wang L, Tang W et al.. “FANS-UAS under local anesthesia for urinary stones with high risk-postoperative urosepsis.” International journal of surgery (London, England) (2025). PMID: 41405295 ↗
L2bCited in: Acute Management & Decompression - [244]
Kazemi R, Najafabadi HM, Norouzi M et al.. “The efficacy of 0.25% bupivacaine infiltration in tubeless percutaneous nephrolithotomy in singular stone of the pelvis: A randomized clinical trial.” Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences (2025). PMID: 41623444 ↗
L1bCited in: Acute Management & Decompression - [245]
Tzeng M, Uzzo R, Kusin S et al.. “Influence of primary language on follow-up after emergency department visits for acute renal colic: evidence from an ethnically diverse urban cohort.” World journal of urology (2026). PMID: 42565869 ↗
L3bCited in: Acute Management & Decompression - [246]
Hanessian K, Albaghli A, Crew R et al.. “The effect of negative, single and multi-organism positive cultures on outcomes following PCNL.” BJUI compass (2026). PMID: 41488808 ↗
L3bCited in: Acute Management & Decompression - [247]
Ballantyne CC, Islam NS, Lin AJ et al.. “Are We Overreporting Post-Op Sepsis? The Difference Between Reported and Verified Rates of Post-Ureteroscopy Sepsis Using the Sepsis 3 Criteria at a Single Institution.” Journal of endourology (2025). PMID: 41253383 ↗
L4Cited in: Acute Management & Decompression - [248]
Aboelmagd K, Yoon S, Sivakuganandan A et al.. “Pre-operative zoledronate is safe for children with medical complexity undergoing posterior spinal fusion for neuromuscular scoliosis.” Spine deformity (2025). PMID: 41310317 ↗
L3bCited in: Acute Management & Decompression - [249]
Thapa BB, Thapa S, Thapa N et al.. “Safety and efficacy of total tubeless mini-PCNL in the management of renal stones: prospective observational study.” BMC urology (2025). PMID: 41013445 ↗
L3bCited in: Acute Management & Decompression - [250]
Sobel D, Caffery P, James E et al.. “A prospective study to determine the safety and feasibility of opioid-free discharge after percutaneous nephrolithotomy.” Translational andrology and urology (2025). PMID: 40529026 ↗
L4Cited in: Acute Management & Decompression - [251]
Lokeshwar SD, Choksi AU, Smani S et al.. “A Novel Electronic Health Record-Integrated Clinical Pathway for Nephrolithiasis: Development and Management Outcomes.” Urology practice (2025). PMID: 40459510 ↗
L3bCited in: Acute Management & Decompression - [252]
Önal HG, Nalçacioğlu H, Karali DT et al.. “Disruptions in Tiopronin therapy: impacts on clinical outcomes of pediatric cystinuria patients during the COVID-19 pandemic.” Urolithiasis (2025). PMID: 40445369 ↗
L3bCited in: Acute Management & Decompression - [253]
Hemo O, Haifler M, Shvero A et al.. “Persistent Unilateral Nephrolithiasis: Do 24-h Urine Parameters Account for It?” Journal of clinical medicine (2026). PMID: 42739734 ↗
L3bCited in: Pathophysiology & Mechanism - [254]
Chen BJ, Uk JJ, Shen CH et al.. “Cross-Species Identification of Urinary Small Extracellular Vesicle-Associated miR-223-3p as a Candidate Biomarker for Nephrolithiasis in a Discovery Cohort.” International journal of medical sciences (2026). PMID: 42807802 ↗
L2bCited in: Pathophysiology & Mechanism - [255]
Ayres DC, Pimenta R, Dos Santos GA et al.. “Exploring the Impact of miR-10a, miR-141, miR-200a and miR-3658 on Cystinuria.” Biomedicines (2026). PMID: 42652071 ↗
L4Cited in: Pathophysiology & Mechanism - [256]
Broughton SE, Frykfors von Hekkel A, Rossanese M et al.. “Subcutaneous ureteral bypass explantation in 21 cats (2015-2023): outcomes and owner perceptions.” Journal of veterinary internal medicine (2026). PMID: 42685338 ↗
L4Cited in: Pathophysiology & Mechanism - [257]
Yang Y, Yang Y, Ouyang J et al.. “Total flavonoids of Desmodium styracifolium attenuate nephrolithiasis via reducing calcium oxalate crystallization and renal inflammation.” Frontiers in pharmacology (2026). PMID: 42827536 ↗
L5Cited in: Pathophysiology & Mechanism - [258]
Wang J, Liao Z, Liu M et al.. “Novel insights into the role of the renal interstitial microenvironment in Randall's plaque formation (Review).” International journal of molecular medicine (2026). PMID: 42825349 ↗
L5Cited in: Pathophysiology & Mechanism - [259]
Ivănuță M, Puia D, Ivănuță AM et al.. “SGLT2 Inhibitors in Nephrolithiasis: Emerging Evidence and What Urologists Need to Know.” Medical sciences (Basel, Switzerland) (2026). PMID: 42783428 ↗
L5Cited in: Pathophysiology & Mechanism - [260]
Li Y, Li Y, Zhang J et al.. “Integrative Genomic and Transcriptomic Analysis Reveals Hypothesis-Generating Candidate Genes for Nephrolithiasis Susceptibility in Primary Hyperoxaluria.” Nephrology (Carlton, Vic.) (2026). PMID: 42775502 ↗
L5Cited in: Pathophysiology & Mechanism - [261]
Yang J, Wang B, Xun Y et al.. “Integrative transcriptomic and single-cell analyses identify CD74 as a candidate regulator of ferroptosis in renal tubular cells during nephrolithiasis.” Renal failure (2026). PMID: 42768906 ↗
L5Cited in: Pathophysiology & Mechanism - [262]
Li S, Zhou Y, Wei D et al.. “Adenine promotes renal calcium oxalate crystallization involving disruption of the intestinal barrier and altered SLC26A3 and SLC26A6 expression.” The Journal of nutritional biochemistry (2026). PMID: 42763032 ↗
L5Cited in: Pathophysiology & Mechanism - [263]
Wang F, Li Q, Wen Q et al.. “Liraglutide and renal mitochondrial homeostasis: targeting the "metabolism-inflammation-lithogenesis" axis in metabolic syndrome.” Frontiers in pharmacology (2026). PMID: 42761830 ↗
L5Cited in: Pathophysiology & Mechanism - [264]
He Q, Song Z, Jiang Z et al.. “FABP1-Mediated Lipid Metabolic Reprogramming Buffers Lipotoxicity in Nephrolithiasis via Maintaining PPARγ Activity.” FASEB journal : official publication of the Federation of American Societies for Experimental Biology (2026). PMID: 42757653 ↗
L5Cited in: Pathophysiology & Mechanism